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ABSTRACT 
 
Implantation of the embryo into the wall of the uterus is a crucial event in mammalian 
embryogenesis. This complex event involves a series of interactions between the developing 
embryo and the receptive endometrium ultimately leading to successful establishment of 
pregnancy. The sequential events of implantation include apposition of the blastocyst
 
to the 
uterine luminal epithelium followed by adhesion to the epithelium and then penetration through 
the epithelium and basal lamina into the uterine stroma. Uterine sensitivity with respect to 
implantation has been classified as prereceptive, receptive,
 
and nonreceptive phases. In the 
mouse, day 1–3 of pregnancy constitutes the prereceptive phase and day 4 is considered 
receptive. The window of uterine receptivity is transient and lasts for a limited time. On day 5 of 
pregnancy, the uterus is nonreceptive or refractory. Studies over the past decade have identified a 
variety of molecules including growth factors, cytokines, transcription factors, and extracellular 
matrix proteins as potential regulators of this complex process. This dissertation work 
investigates the critical role of Msx homeobox genes in the uterus during embryo implantation.  
 
The mammalian Msx homeobox genes, Msx1 and Msx2, encode transcription factors that control 
organogenesis and tissue interactions during embryonic development. Uterine specific deletion 
of Msx1 and Msx2 resulted in female infertility due to a failure in implantation. Further analysis 
indicated that mice lacking uterine Msx1 and Msx2 (Msx1
d/d
Msx2
d/d
) exhibited a failure in uterine 
receptivity due to enhanced estrogen signaling in the luminal epithelium, failure of microvilli 
remodeling, sustained epithelial cell polarity and persistent proliferative activity of luminal and 
glandular epithelium. More recent studies revealed that canonical Wnt/ β-catenin signaling were 
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upregulated in the Msx1Msx2-null uteri, which in turn stimulated the production of a subset of 
fibroblast growth factors (FGFs) in the stromal cells. The FGFs subsequently activate FGFR-
ERK-MAP kinase signaling pathway in the luminal epithelium resulting in sustained epithelial 
cellular proliferation. These results uncovered a unique signaling network, involving Msx1/2, 
Wnts, and FGFs, which regulate stromal-epithelial cross talk in the mouse uterus at the time of 
receptivity. 
 
The last chapter addresses the role of Msx homeobox genes during uterine stromal cell 
decidualization. As the embryo attaches to the uterine wall and invades into the stromal bed, the 
stromal cells surrounding the implanting blastocyst differentiate into decidual cells in a process 
known as decidualization. This process is critical for embryo survival, angiogenesis and 
successful establishment of pregnancy. We previously reported that Bone morphogenetic protein 
2 (BMP2) regulates uterine stromal cell differentiation in the mouse and the human. Subsequent 
studies revealed that the expressions of Msx1 and Msx2 were markedly altered in response to 
exogenous BMP2. Functional studies performed using Msx1
d/d
Msx2
d/d
 mice revealed that mouse 
uteri lacking Msx1 and Msx2 fail to elicit a decidual response, indicating a critical role of these 
homeobox genes in stromal cell differentiation. Further studies revealed that the addition of 
BMP2 stimulated MSX1 and MSX2 expression in human endometrial stromal cell cultures and 
enhanced the differentiation process. Silencing of MSX1 or MSX2 expression by siRNAs 
severely impaired human stromal differentiation indicating that MSX1 and MSX2 are key 
regulators of BMP2-mediated decidualization in the mouse and the human. 
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CHAPTER I  
INTRODUCTION AND REVIEW OF LITERATURE 
 
1.1 INTRODUCTION 
 
The endometrium is a specialized dynamic tissue that undergoes sequential events of 
proliferation, differentiation, regression and regeneration during the reproductive cycle in 
response to ovarian steroids, estrogen and progesterone [1-5]. In each cycle, the endometrium 
becomes competent for implantation for a short period of time termed as the “window of uterine 
receptivity” during which the blastocyst will be allowed to attach to the uterine wall [6-9]. In 
rodents, it occurs on day 4 of pregnancy (the day of vaginal plug is day 1 of pregnancy) and lasts 
only for 24h [3,4,8,10,11]. In humans, the uterus enters the receptive phase during the mid-
secretory phase, between cycle days 20 to 24 (6 to 10 days after ovulation) and lasts for about 5 
days [12-14].  
 
The acquisition of uterine receptivity is a critical step during embryo implantation and any 
perturbation in this step causes infertility [6]. Assisted reproductive technologies including in 
vitro fertilization (IVF) are the most commonly sought medical procedures to treat infertility 
[15]. However, the average implantation rate in IVF is only ~25% [16]. The recurrent 
implantation failure (RIF) is a major attributed factor for this reduced success rate [17-19]. 
Failure to achieve a pregnancy following 2–6 IVF cycles, in which more than 10 high-grade 
embryos were transferred to the uterus, was defined by various clinicians as RIF [20]. It is 
believed that two-thirds of implantation failures in RIF are due to an altered uterine receptive 
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status of the endometrium [21], while the embryo itself is responsible for one-third of these 
failures [12,22].  
 
The diminished uterine receptivity is also observed during controlled ovarian stimulation used in 
IVF [23]. In addition, the common gynecologic disorders, including thin endometrium [24], 
endometriosis [25,26], polycystic ovarian syndrome [27], hydrosalpinges [28,29] and luteal 
phase defect, appear to exhibit impaired uterine receptivity [30]. Any alteration in uterine status 
is generally evaluated by histological techniques, biochemical changes in the endometrial fluid 
and altered expression of critical endometrial factors [31,32].  
 
The histological evaluation of the endometrium has been the gold standard for clinical diagnosis 
for the past five decades [31]. However, its accuracy and the functional relevance of this system 
as predictor of receptivity have been questioned in recent randomized studies due to a high 
degree of variability in results [12]. Hence, it is necessary to identify new markers of endometrial 
receptivity.  
 
To invent new technique to manipulate uterine receptivity during clinical interventions, it is 
imperative to understand the basic molecular mechanism of this intriguing process. As of now, it 
is impossible to study uterine receptivity by using in vitro human cell culture system. Hence, it is 
necessary to find a suitable animal model [1,33]. The availability of genetically engineered 
mouse models, the existence of evolutionarily conserved pathways in rodents and humans and 
similarities in the implantation process such as uterine stromal cell decidualization make the 
mouse an attractive animal model to study uterine receptivity [2]. 
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1.2 UTERINE RECEPTIVITY 
 
1.2.1 Physiological events during uterine receptivity 
The fertilized oocyte or zygote undergoes a series of cleavage divisions to become blastocyst. In 
mice, the blastocyst enters the uterine cavity on day 4 of pregnancy. At the same time, the uterus 
prepares itself to become competent to receive the blastocyst. In mice, the uterus is considered 
pre-receptive on days 1–3 of pregnancy, receptive on day 4 and is non-receptive after day 5 [3].  
During the receptive phase, the blastocyst interacts with the uterine epithelium through three 
sequential steps: apposition, adhesion, and invasion [1,34,35]. During apposition, the 
trophectoderm cells will be closely apposed to the uterine luminal epithelium. In mice, the 
blastocysts are oriented with their inner cell mass (ICM) directed towards the mesometrial side 
of the uterus, whereas in humans the ICM is directed towards the antimesometrial side. During 
adhesion, the intimacy and adherence between the trophectoderm and the luminal epithelium will 
be further strengthened. The generalized edema occurring in the uterine stroma and subsequent 
closure of the uterine lumen will aid these processes significantly. The edema is due to localized 
increase in stromal vascular permeability which can be visualized as distinct blue bands upon 
intra venous injection of a Chicago blue dye [36]. During the third stage, the trophectoderm 
penetrates the luminal epithelium and invades the uterine stromal compartment [4].  
 
1.2.2 Ultra-structural changes of uterine epithelium during receptivity 
The uterine epithelium undergoes a remarkable ultrastructural change during the receptive phase. 
On day 1 of pregnancy, the epithelium is of ciliated columnar type, which will transform into a 
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cuboidal type on day 4 of gestation. In addition, the epithelium will display flattening of 
microvilli and the loss of epithelial cell polarity [37]. 
 
Microvilli flattening of uterine epithelial cells 
The microvilli on the apical surface of the cells undergo characteristic changes during 
receptivity. In the pre-receptive period, the apical plasma membrane will be layered with long 
thin microvilli and covered with carbohydrate containing coat or glycocalyx which acts as a 
physical barrier [37].  During the receptive phase, the apical plasma membrane of uterine 
epithelial cells gradually loses regular microvilli and becomes flat on d 4 of pregnancy [38,39]. 
This microvilli flattening and subsequent reduction in the level of glycocalyx is an important 
process to facilitate the embryo attachment.  
 
Loss of epithelial cell polarity 
The polarity of the uterine luminal epithelial cells is believed to be maintained by various cell-
cell junctional complexes (adherens junctions, tight junctions and desmosomes) located at the 
basolateral membrane [40]. Similar to apical plasma membrane, the baso-lateral membrane will 
also undergo changes during uterine receptivity. The adherens junction as well as its associated 
terminal web will be lost completely from the lateral plasma membrane [37]. The family of 
calcium dependent cell–cell adhesion molecules such as E-cadherin, is highly expressed at the 
adherens junctions during the prereceptive period; however, its level is downregulated during 
uterine receptivity [41,42]. The desmosome proteins are also reported to be down regulated 
during the receptive period [37]. 
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1.2.3 Molecules regulating uterine receptivity 
Research over the past decade has identified a variety of molecules involved in the regulation of 
uterine receptivity. Through studies using mutant mouse models, global as well as conditional 
knockouts, report the critical factors that are involved in this process [3,43].  The mutant mouse 
models exhibiting lack of uterine receptivity are listed in the following table. 
 
Table 1 Mutant mouse models exhibiting infertility phenotype due to lack of uterine 
receptivity 
Genes Protein Spatial expression 
Temporal expression 
(Days of pregnancy) 
4              5 
References 
Lif Cytokine GE + - [44] 
Esr1 TF 
LE + - 
[45,46] GE + + 
S + + 
Pgr  TF 
LE + - 
[47,48,49] GE + + 
S + + 
C/EBPβ TF E, S N/A N/A [50] 
Fkbp52 Chaperone 
LE, GE ++ + 
[51] 
S + +++ 
Ihh Ligand LE,GE + - [52] 
COUP-TFII TF S + + [53] 
Hand2 TF S + + [54] 
 
(TF – Transcription factor; GE – Glandular Epithelium; LE – Luminal Epithelium; S – 
Stroma; N/A – Not Available) 
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Leukemia Inhibitory Factor  
Leukemia Inhibitory Factor (LIF), a member of the interleukin (IL)-6 family, is a highly 
glycosylated 40–50 kDa glycoprotein with multiple biological functions [55]. In mice, it is 
transiently expressed in the luminal epithelium on day 1 of pregnancy and is expressed in 
glandular epithelium on the morning of day 4 of pregnancy [56]. In ovariectomized mice, uterine 
LIF mRNA is induced within 1 h of estrogen injection and is not affected by progesterone, 
suggesting that it might be regulated by estrogen [56]. An elegant study conducted using the LIF 
null mouse model unequivocally established the role of LIF in mouse uterus during uterine 
receptivity. In the absence of LIF, embryos developed normally but they fail to attach to the 
uterine epithelium [44]. 
 
Estrogen receptor 
Estrogens are indispensable for female reproductive functions. The physiological effects of 
estrogens are mediated by the estrogen receptor, a member of the nuclear receptor superfamily of 
transcription factors. Two estrogen receptors have been identified: estrogen receptor alpha (ERα) 
and estrogen receptor beta (ERβ) [57]. The ERα is predominant form expressed in the uterus. It 
is localized primarily in the luminal and glandular epithelia on days 1 and 2 of pregnancy. On 
days 3 and 4, it is localized in both stroma and epithelium [58,59]. Three different estrogen 
receptor knockout (ERKO) mouse models carrying a null mutation in the ERα gene (αERKO), 
the ERβ gene (βERKO) or both genes (αβERKO) have been generated. Both αERKO and 
αβERKO female mice are infertile and exhibit impaired uterine receptivity [45,46]. However, 
βERKO female mice do not exhibit obvious uterine defects [46,60]. 
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Progesterone receptor 
The steroid hormone progesterone is considered a pregnancy hormone. The progesterone 
receptor, a member of the nuclear receptor superfamily of transcription factors, mediates 
physiological effects of progesterone [49,61-67]. On day 1 and 2 of pregnancy, the expression 
level of PR is low. On day 3, a marked increase in the level of PR is observed in the epithelium. 
On day 4, while the PR level is reduced in the epithelium the expression goes up in the stroma 
[58,62]. The PRKO mouse, in which both PRA and PRB isoforms are deleted, is infertile due to 
multiple reproductive defects including lack of uterine receptivity [47].  Knockout mouse models 
specific for the PR isoforms have been generated. The female PRA isoform knockout (PRAKO) 
mouse is infertile and displays defects similar to PRKO mice [63]. In contrast, the PRB isoform 
knockout (PRBKO) mouse is fertile [68]. 
 
C/EBPβ 
C/EBPβ, a transcription factor belongs to C/EBP family of basic leucine-zipper proteins, is a 
critical regulator of proliferation and/or differentiation in multiple tissues. It is expressed in both 
the uterine epithelium and stroma in response to estrogen and progesterone. The female C/EBPβ-
null mice are infertile due to a defect in uterine receptivity [50,69,70]. 
 
Indian Hedgehog 
Indian hedgehog, a member of the hedgehog family of proteins, was identified as a PR target 
gene in mouse uterus. It is maximally expressed in uterine epithelium on day 3 of pregnancy. 
Conditional deletion of this gene in mouse uterus resulted in loss of uterine receptivity and 
infertility [52,71,72]. 
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COUP-TFII 
 COUP-TFII (Chicken ovalbumin upstream promoter transcription factor II, also known as 
NR2F2), a member of the nuclear receptor superfamily, is highly expressed in the uterine stroma. 
It is expressed in mouse uterus during early pregnancy in response to progesterone–Indian 
hedgehog signaling. Similar to PR and Ihh mutant mouse models, the conditional deletion of 
COUP-TFII rendered the mice infertile due to lack of uterine receptivity [53,73]. 
 
Hand2 
Hand2 (Heart and neural crest derivatives expressed protein 2) is a basic helix-loop-helix 
transcription factor. Its expression is restricted to uterine stromal cells and is controlled by the 
progesterone receptor during early pregnancy. Conditional ablation of Hand2 in mouse uterus 
resulted in normal ovarian function and proper embryo development; however, the embryos 
failed to attach to the uterine epithelium due to lack of uterine receptivity [54]. 
 
FKBP52 
FKBP52/FKBP4 is a member of FK506 binding family of immunophilins and functions as a 
cochaperone to PR. The overlapping expression pattern of FKBP52 and PR was observed on day 
4 and 5 of pregnancy in mouse uterus. The female null mice were infertile due to lack of uterine 
receptivity [51]. 
 
1.2.4 Endometrial glands and uterine receptivity 
Endometrial glands are an integral part of mammalian uteri and their secretions are critical 
regulators of peri-implantation embryo survival and establishment of uterine receptivity [74-79]. 
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However, the composition of endometrial secretions has not been fully characterized. The critical 
factors like LIF [56], Foxa2 [80], and Spink3 [81] are exclusively expressed in the uterine glands 
at the time of receptivity. The indispensable role of endometrial glands in uterine function has 
gained much attention when mice lacking uterine glands or LIF were generated [44]. The 
endometrial glands failed to develop in sheep [82,83] and mice [84] when treated with 
progesterone during their neonatal life and in Wnt5a [85], Wnt7a [86-88] and β-catenin [89] 
knockout mouse models. The uteri of these animals failed to achieve receptive phase during their 
adult life.  
 
1.2.5 Stromal-epithelial cross talk during uterine receptivity 
It is well known that the interactions between uterine stromal cells and epithelial cells play a 
critical role in the regulation of uterine receptivity [90-93]. Conventional tissue recombination 
studies provided insight into this process [94]. Recently, the development of compartment 
specific conditional knockout mouse models further confirmed the stromal-epithelial cross-talk 
during uterine receptivity and is contributing tremendously to reveal the underlying molecular 
mechanism [48,95]. 
 
1.2.5.1 Uterine epithelial cell proliferation and differentiation during uterine receptivity 
In mice, the concerted action of estrogen and progesterone regulate proliferation and/or 
differentiation of uterine epithelial cells during the window of implantation [96-99].  On the first 
day of pregnancy in mice, the preovulatory estrogen secretion induces epithelial cells to 
proliferate and the increasing levels of progesterone secreted from freshly formed corpora lutea 
induce epithelial cell differentiation [1,4,64,97,100]. The sequential events of epithelial cell 
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proliferation and differentiation are achieved by interactions between the molecules expressed in 
the uterine stroma and epithelium [67,90]. 
 
E through stromal ER induces epithelial cell proliferation 
By using tissue recombination technique, it was demonstrated that the stromal ER is necessary to 
induce epithelial cell proliferation [94]. This was further confirmed in studies involving 
epithelial specific ERα mutant mouse models. In this model it was clearly observed that the E2-
induced uterine epithelial proliferation is dependent on stromal ER and epithelial ERα is 
dispensable in this process [95]. 
 
Growth factors mediate epithelial cell proliferation 
Administration of estrogen to ovariectomized mice mediates epithelial cell proliferation by 
inducing growth factors such as EGF [101,102], IGF1 [103] and TGFα [104]. While these 
growth factors are mostly expressed in the uterine stroma, the receptors corresponding to those 
growth factors are shown to be expressed mostly in the neighboring epithelial cells [105].  
 
P through stromal PR/Hand2 inhibits E induced epithelial cell proliferation 
Tissue recombination studies revealed that P mediates its inhibitory effects on E induced 
epithelial proliferation through stromal PR [106]. In an elegant study from our laboratory, it was 
reported that the conditional ablation of Hand2, a PR target gene in mouse uterus, caused 
upregulation of FGF family members Fgf2, Fgf9, and Fgf18 in uterine stroma. This resulted in 
the activation of FGFR/ERK1/2 signaling in the uterine epithelium which ultimately prevented 
the uterine epithelium from undergoing differentiation to achieve the receptive phase [54].  
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1.2.5.2 PR/IHH-PTCH1/COUP TF II regulates uterine receptivity 
P through PR and its downstream signaling pathways regulate uterine receptivity. It has been 
identified that Ihh is the major mediator of progesterone signaling in the uterus at the time of 
receptivity [52]. It is expressed exclusively in the uterine luminal and glandular epithelium 
during pre-receptive and receptive phases of the uterus. However, its receptor, Ptch1 and the 
downstream targets, Gli1 and 2 are expressed in the uterine stroma [71,107]. COUP TFII, 
reported be a downstream mediator of Ihh signaling, is expressed exclusively in the uterine 
stroma[53]. These studies clearly demonstrate that PR/IHH-PTCH1/COUP TF II pathways 
regulate uterine receptivity through stromal-epithelial cross talk [67]. 
 
1.2.6 Markers of uterine receptivity 
The identification of the receptive stage of the uterus is the critical determining factor for the 
success of assisted reproductive technologies including IVF [12,108]. The reliable marker is 
expected to be exclusively expressed in the endometrium at the time of receptivity and to be 
easily identified with a simple procedure even in the routine clinical settings. There are various 
markers that have been identified but used with little success. Hence, the search to identify the 
definitive marker of uterine receptivity continues [109]. At present, the following are considered 
to be potential markers of uterine receptivity. 
 
Pinopods 
Scanning electron microscopy of endometrial samples demonstrated that pinopods are a good 
marker of uterine receptivity. Pinopods are smooth mushroom like projections that arise from the 
apical surface of the luminal epithelium of the endometrium, measuring several micrometers in 
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diameter [108,110]. These structures have been identified in a variety of animals, however, with 
notable morphological differences in shape, size and content. The duration of their presence in 
species also varies between hours to weeks. In the rat, their presence is reported to be mostly 
around the time of implantation. But in mice and human, there are conflicting reports on the 
duration of pinopods and their use as a marker of uterine receptivity [109,110].  
 
MUC1 
The apical surface of uterine epithelial cells is protected by a thick glycocalyx composed mostly 
of mucins. Among all mucins, Mucin-1 (MUC1) is found to be the major subtype in the mice 
and human endometrium [111-113]. It is expressed on day 1 of pregnancy and is down-regulated 
before implantation in the receptive mouse endometrium to facilitate embryo attachment 
[114,115]. Hence, its disappearance is essential for the achievement of endometrial receptivity 
and is considered a marker of receptive uterus [108,109]. 
 
Other markers 
The other potential endometrial biomarkers include ανβ3 integrin, LIF, E-cadherin, trophinin, L-
selectin ligand, prostaglandins, IL6 and heparin-binding epidermal growth factor. These factors 
are still being investigated to assess their usefulness as a marker of endometrial receptivity 
[108,109,116]. 
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1.3 UTERINE STROMAL CELL DECIDUALIZATION 
 
Differentiation of endometrial stromal cells to decidual cells in a process termed as 
decidualization is a critical event during early pregnancy. In mice, decidualization is initiated 
when the embryo attaches to the receptive epithelium on day 4 of pregnancy [117,118]. After the 
attachment, the embryo penetrates the luminal epithelium and invades into the uterine stroma. In 
response to embryo attachment and invasion, the stromal cells surrounding the implanted embryo 
will undergo extensive proliferation and differentiation to become functionally and 
morphologically distinct decidual cells [4]. In the human, the stromal cell differentiation occurs 
during the secretory phase of every menstrual cycle even in the absence of embryo. This initial 
process of predecidualization, however, will become more pronounced in the presence of 
embryo.  The decidual cells are involved in the secretion of variety of factors which regulate 
embryonic growth and trophoblast invasion during early pregnancy [118]. The precise 
mechanism of decidualization is not clearly understood, though there are a number of factors that 
have been implicated in the formation and function of decidua [118]. Some of these factors are 
listed below. 
 
1.3.1 BMP2 and WNT4 
Bmp2 is a member of the BMP family of morphogens and is a downstream target of PR in the 
mouse uterus [119]. It is expressed in the uterine stromal cells at the site of attachment and 
persists through the early phases of decidualization. Mutant mice lacking uterine BMP2 fail to 
elicit decidual response clearly indicating an essential role of this factor in decidualization [120]. 
Further studies showed that a conserved pathway involving BMP2 also plays a critical role in 
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human endometrial stromal cell differentiation. [121]. the wingless-related MMTV integration 
site 4 or Wnt4 is expressed downstream of BMP2 signaling during endometrial stromal cell 
differentiation [121]. In Wnt4 null uteri, decidualization is impaired [122]. These mice failed to 
undergo the decidual response in response to deciduogenic stimuli. Its importance in regulating 
human stromal cell differentiation was studied by using primary endometrial stromal cell culture 
[121]. 
 
1.3.2 Connexin 43 
Connexin 43 (Cx43), a major gap junction protein, is expressed in uterine stromal cells 
surrounding the implanted embryo during decidualization. The mice uteri lacking Cx43 gene in 
their stromal cells exhibited disrupted gap junctions and impaired decidualization. This causes 
defective neovascularization within the uterine decidua resulting in the embryo resorption and 
early pregnancy loss [123].  
 
1.4 HOMEOBOX GENES 
 
The evolutionarily conserved homeobox genes are first identified in Drosophila [124,125]. Soon 
after, the homologous genes were found in various animal species [126,127]. They are 
characterized by a conserved 180-bp DNA sequence (Homeobox) coding for a 60-aminoacid 
DNA-binding domain called the ‘homeodomain’ [128]. They function as transcription factors 
recognizing specific DNA sequences and regulate target genes [127]. Homeodomain containing 
proteins are considered as master regulators of embryonic development and play crucial roles in 
axial patterning, specifying cell identity and proliferation during embryonic development [125]. 
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Mutations in these genes can cause dramatic developmental defects including loss of specific 
structures as well as changes in the identity of a body part or segment, which are known as 
‘homeotic transformations’ [128]. 
 
More than 200 vertebrate homeobox genes have been identified in a variety of species [129]. 
Based on sequence homology among their respective homeodomains, homeobox genes are 
categorized into two large groups. Class I genes, called Hox genes, share a high degree of 
identity (>80%), with the first discovered homeobox gene of Drosophila, called Antennapedia, in 
their homeodomain [129]. In mammals, there are 39 Hox genes and are organized in four 
clusters, labeled as A, B, C and D. Each cluster is divided into 13 paralogous families on the 
basis of sequence similarity and chromosomal position within each linkage group. There is a 
correlation between the position of Hox genes in the cluster and their expression pattern along 
the anterior-posterior axis of the body, with genes located most 5’ in the cluster expressed most 
posteriorly while the more 3’ located genes are expressed in more anterior regions[125]. The 
class II, or diverged homeobox genes, exhibit less than 50% identity with the Antp gene. Class II 
homeobox genes are grouped into many subfamilies, such as MSX, PAX, POU, EMX, and OTX, 
based on the presence of additional conserved sequences [129,130]. 
 
1.4.1 Homeobox genes and reproductive system 
The homeobox genes regulate the development of reproductive system during embrogenesis and 
postnatal life [125,131]. The Hoxa9, Hoxa10, Hoxa11 and Hoxa13 genes regulate the 
differentiation of the Müllerian ducts into adult genital structures. The expression of Hoxa9 is 
limited to the fallopian tube; Hoxa10 is expressed in the uterine epithelium, stroma and muscle; 
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Hoxa11 is expressed in the uterine stroma, cervical glands and epithelium; and Hoxa13 is 
expressed in the vaginal epithelium [132,133]. In addition to playing a major role in the 
development of reproductive organs, they also critically regulate their function during adult life 
[133]. For example homeobox genes are known to regulate uterine function during pregnancy 
[134-136].  Hoxa-10 mutant mice exhibit oviductal transformation of the proximal one third of 
the uterus. Further, blastocyst implantation and decidualization were impaired in adult Hoxa10 
null mice [137]. The reduced proliferation of uterine stromal cells in response to progesterone 
was identified as the main cause of decidualization defect in these mice [138]. The uterine 
stromal cell proliferation was also severely impaired in Hoxa11-deficient mice [139]. 
Additionally, these mice exhibit hypoplastic uteri and lack of uterine glands.  
 
1.5 MSX HOMEOBOX GENES 
 
The Msx is a sub-family of class II homeobox gene superfamily [140]. They were initially cloned 
from mice and were identified as homologous to the Drosophila muscle segment homeobox gene 
(msh) [141,142]. Later, Msx genes have been identified from a variety of organisms, including 
ascidians, sea urchin, zebrafish, frogs, birds, and humans[143]. The mammalian Msx gene family 
consists of 3 members, namely Msx1 (Hox 7.1), Msx2 (Hox 8), and Msx3 and are chromosomally 
unlinked residing on chromosomes 5, 13 and 7 respectively [144]. Msx1 and Msx2 are widely 
expressed in many organs during embryogenesis [141,145-148]. However, Msx3 is only 
expressed in the dorsal neural tube [149,150].   
 
1.5.1 Role of Msx during gene transcription 
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The Msx proteins are important modulators of craniofacial, tooth, limb, skin, mammary gland 
and nervous system development [143,144,151]. They function as transcriptional repressors in 
vitro and in vivo by interacting directly with the TATA binding protein (TBP) [152,153]. They 
also interact with other homeodomain proteins such as Dlx2, Dlx5, Lhx2 and Pax3 to regulate 
transcription [154,155,156].  
 
1.5.2 Msx and human diseases 
Mutation in human MSX1 and MSX2 genes causes diseases.  Loss of function mutations in MSX1 
causes Witkop syndrome [157,158] and Wolf-Hirschhorn syndrome [159]. A gain of function 
mutation in MSX2 causes Boston type craniosynostosis [160] and loss of function mutation 
causes Familial Parietal Foramina [161]. 
 
1.5.3 Functional redundancy of Msx1 and Msx2  
Biochemical studies revealed that MSX1 and MSX2 have common DNA-binding and 
transcriptional properties and they both recognize the same DNA consensus site [162]. Their role 
during development and their functional redundancy are clearly demonstrated after the 
generation and analysis of knockout mouse models. Msx1 null mice are neonatally lethal due to 
defects in the development of teeth and cleft palate [163]. Msx2 null mice are viable and fertile, 
but exhibit defects in the development of the skin, teeth, jaws, skull vault and mammary gland 
[164]. However,  Msx1/2 null mice with mutations of both Msx1 and 2 die at E16 – E18 and 
display more severe phenotype than the loss of any one during cranial and cardiac neural crest, 
CNS, craniofacial complex, ventral body wall, tooth, ear, limb, hair follicle, limb and mammary 
gland development[164-166].  
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1.5.4 Msx expression in the uterus 
Msx genes are expressed in many tissues during embryogenesis; but their levels decline 
significantly soon after birth except in a few tissues like the uterus, mammary gland and skin 
[167-169]. The expression of Msx1 is detected in the Müllerian ductal epithelium on E19 and it 
is expressed in the presumptive uterus, cervix and vagina. Msx1is detected in uterus during 
postnatal period including adulthood. However, the level of Msx1 is greatly reduced in the 
vagina on postnatal day 4-5 and disappears from the cervix at 2 weeks. Thus, Msx1 expression is 
restricted to the presumptive uterus during postnatal development.  In the uterus, it is 
predominantly expressed in the luminal and glandular epithelial cells. In pregnant uteri, the level 
of Msx1 is markedly reduced at 4.5 days p.c. coincident with embryonic implantation and is not 
expressed during decidualization [168]. Unlike Msx1, Msx2 is expressed in the uterine stroma 
during decidualization. [170]. 
 
1.5.5 Msx and signaling pathways 
 
Msx and Wnt 
Msx genes are reported to interact with Wnt signaling in many different tissues. Wnt1 expression 
is induced by Msx1 in the neural tube of the chick embryo and its expression is abolished in 
double Msx1/2 mutants [171]. Immunoprecipitation studies revealed the presence of multiple 
DNA biding sites for Msx1 on Wnt5a gene [172]. Wnt7a expression is greatly up-regulated in 
Msx2 null uterine epithelium compared to wild-type controls [173]. Msx2 induces Wnt3a and 
Wnt7a during vascular calcification [174] and it also promotes osteogenic differentiation by 
enhancing the expression of Wnt7 genes and by downregulating Dkk1 expression [175]. Msx1 
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and Pax3 cooperate to mediate Fgf8 and Wnt signals during Xenopus neural crest development 
[176]. Previous studies also indicated that Msx1 and Msx2 are downstream targets of the 
Wnt/beta-catenin signaling pathway during lip formation and fusion [177]. 
 
Msx, Bmp and Fgf 
Msx genes interact with many growth factor signaling pathways including BMP, FGF, 
endothelin, dhand and SHH during organogenesis [178-181]. It has been reported that BMP2, 
BMP4, FGF2, FGF4, FGF8, and FGF9 from the oral and/or the dental epithelia are capable of 
inducing Msx1 expression in the subjacent mesenchyme of the mandible and maxilla 
[141,182,183]. In particular, the expression of BMPs and MSXs are often co-localized during 
morphogenesis [167,184,185]. The expression of MSX1/2 is induced in response to BMP2/4 
addition in tooth mesenchyme explant [186] and in facial primordia [187]. Interestingly, it has 
also been reported that BMP signaling induces Msx1 which in turn inhibits FGF-ERK signaling 
to cause cardiomyocyte differentiation [188]. 
 
Wnt and Fgf 
The interaction between WNTs and FGFs is well known during different developmental systems, 
including tracheal development in Drosophila, mesoderm induction and neural patterning in 
Xenopus, and early embryogenesis, body-axis formation, limb-bud formation, and neurogenesis 
tooth, and kidney development in other vertebrates [189-192]. During limb development, Wnt2b, 
Wnt-3a and Wnt 8c signal through β-catenin to regulate Fgf 8/10 expression that in turn direct 
limb initiation and apical ectodermal ridge induction [193]. The cross-talk between Wnt and Fgf 
20 
 
signaling pathways has also been reported in human colorectal carcinogenesis, mouse mammary 
tumor virus (MMTV)-induced carcinogenesis, and E2A-Pbx-induced leukemogenesis [194,195]. 
 
Msx and dHAND 
Msx1, Msx2 and the bHLH transcription factor dHAND are expressed in a similar pattern in the 
distal mesenchyme of the branchial arches. In dHAND-null embryos, Msx1 is not expressed and 
the branchial arches become hypoplastic. However, Msx2 expression is unaltered suggesting that 
Msx1 is downstream of dHAND in the mesenchyme of the branchial arches [181]. In contrast, it 
was reported that the expression of both Hand1 and Hand2 is reduced in the Msx1/2 null mutant 
myocardium. Hence, it was suggested that Hand1 and Hand2 are candidate target genes 
regulated by Msx1 and Msx2 during atrio-ventricular valve formation [196]. 
 
1.5.6 Msx and epithelial-mesenchymal interactions 
Epithelial–mesenchymal interactions play a pivotal role during organogenesis in many tissues. 
Interestingly, Msx genes are reported to play critical role in this process during tooth, heart, 
mammary gland and placenta formation [170,184,196-198]. During tooth development, the 
expression of Msx1 in mesenchyme requires an epithelial signal, whereas Msx2 expression in 
either epithelium or mesenchyme requires reciprocal interactions between specialized dental cell 
populations [198]. In the mammary gland, Msx2 expression in stroma requires the presence of 
contiguous epithelium [197]. In tissue recombination experiments conducted using neonatal 
mouse uterine and vaginal tissues, the expression of Msx1 in the uterine epithelium was only 
observed when it was combined with uterine mesenchyme; and not when it was combined with 
vaginal mesenchyme [168]. 
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1.5.7 Msx and Endocrine disruptors 
The neonatal mice exposed to diethylstilbestrol (DES) will encounter a variety of uterine and 
vaginal malformations which have severe impact on their fertility during their adult life [199]. 
The malformations are reported to be caused by changes in the expression of many 
developmental genes including Msx2 [173]. It has been reported that Msx2 is consistently down 
regulated in the uterus of DES exposed animals. Studies have also shown that upon DES 
exposure, Msx2 null uteri exhibit enlarged lumen with a reduction in the amount of stromal tissue 
[173], a complete failure of Müllerian vaginal epithelial stratification and a severely dilated 
vaginal lumen [200]. These reports suggest that Msx2 counteracts the deleterious effects of DES 
during female reproductive tract development. 
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CHAPTER II 
MSX HOMEOBOX GENES CRITICALLY REGULATE UTERINE RECEPTIVITY 
DURING EMBRYO IMPLANTATION 
 
2.1 ABSTRACT 
The mammalian Msx homeobox genes, Msx1 and Msx2, encode transcription factors that control 
organogenesis and tissue interactions during embryonic development. We observed overlapping 
expression of these factors in uterine epithelial and stromal compartments of pregnant mice prior 
to embryo implantation. Conditional ablation of both Msx1 and Msx2 (Msx1/2) in the uterus 
resulted in female infertility; however, the deletion of either one resulted in subfertility. Mice 
deficient of uterine Msx1 and Msx2 (termed as Msx1
d/d
Msx2
d/d
) exhibited normal ovarian 
function and pre-implantation embryo development. Msx1
d/d
Msx2
d/d
 uteri however failed to 
exhibit implantation sites as indicated by blue bands in response to administration of Chicago 
blue dye indicating failure in implantation. In these mutant mice, the uterine epithelium failed to 
attach to the embryos. Further analysis indicated that estrogen signaling was elevated in the 
uterine epithelium of Msx1
d/d
Msx2
d/d
 mice. Transmission electron microscopy of uterine 
epithelium from Msx1
d/d
Msx2
d/d
 mice revealed failure of microvilli remodeling on day 4 of 
pregnancy. In addition, expression of MUC-1 protein, a major component of the microvilli 
glycocalyx during early pregnancy, was greatly enhanced in Msx1
d/d
Msx2
d/d
 mice. The level of 
E-cadherin, a component of adherens junction, was elevated in Msx1
d/d
Msx2
d/d
 uteri indicative of 
sustained epithelial cell polarity. In conclusion, the loss of Msx1/2 prevents the uterine 
epithelium to achieve functional receptive status. Collectively, these findings demonstrate that 
Msx1/2 critically regulate uterine receptivity during embryo implantation. 
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2.2 INTRODUCTION 
 
The heterogeneous cellular compartments of the uterus, (luminal and glandular) epithelium and 
stroma, contribute in distinct ways to the proper functioning of the endometrium and its 
interaction with the blastocyst during implantation process [1,3,4]. During each cycle, the 
endometrium becomes competent for a short period of time, termed as the window of uterine 
receptivity, during which the blastocyst will attach and implant to the uterine wall [6,8,201]. In 
rodents, it occurs on day 4 of pregnancy (the day of vaginal plug is day 1 of pregnancy) and lasts 
for 24h [1,2,11]. The receptive phase is comprised of distinct phases including apposition, 
adhesion, and invasion.  During apposition, the trophectoderm cells will be closely apposed to 
the uterine luminal epithelium. This interaction between the two cellular components will 
become more intimate and will be strengthened at the adhesive phase. The generalized edema 
occurring in the uterine stroma and subsequent closure of the uterine lumen will aid these 
processes significantly [4]. The edema is due to localized increase in stromal vascular 
permeability which can be visualized as distinct blue bands upon intra venous injection of a 
Chicago blue dye [36].  
 
Extensive research over the past decade using genetically altered mutant mouse models, has 
identified several factors that critically regulate uterine function during embryo implantation [50-
54,120,123,202-207]. However, there is only limited insight into the molecular mechanisms and 
signaling pathways that interconnect the various cellular compartments of the uterus to render it 
receptive to embryo implantation. In the present study, we investigated the role of Msx 
homeobox genes in regulating uterine receptivity. 
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The Msx transcription factors belong to the superfamily of homeobox genes. They were initially 
identified as homologous to the Drosophila muscle segment homeobox gene (msh). The 
mammalian Msx gene family consists of 3 members, such as Msx1 (Hox 7.1), Msx2 (Hox 8), and 
Msx3 [141,143,144]. Msx1 and Msx2 are widely expressed in many organs during 
embryogenesis [147,208]. However, Msx3 is expressed only in the dorsal neural tube [150].  It 
was previously reported that Msx1 and Msx2 are expressed in the neonatal as well as in adult 
mouse uterus [168,173,209]. We observed that MSX1 and MSX2 are expressed in an 
overlapping pattern in the epithelial and stromal compartments of the preimplantation uterus 
during days 1-4 of pregnancy. Expressions of MSX1 and MSX2 were markedly reduced in both 
compartments following embryo attachment. These findings raised the possibility that the 
pathways regulated by MSX1 or MSX2 or both regulate the receptive state of the 
preimplantation uterus.  
 
Msx1 null mice are neonatally lethal due to defects in the development of teeth and cleft palate 
[163]. Msx2 null mice are viable and fertile, but exhibit defects in the development of skin, teeth, 
jaws, skull vault and mammary gland [164]. The double Msx1/2 null mice die at E17 – E18 
[165,166]. Hence, it is necessary to conditionally delete these genes in the uterus to study their 
functions during implantation. We generated mutant mice in which Msx1/2 are ablated in uterine 
cells by using cre-lox technology. We observed that ablation of uterine Msx1/2 leads to infertility 
in mice. The results of superovulation experiment and analysis of hormonal profiles indicate 
normal functioning of hypothalamus-pituitary-ovarian axis in animals lacking Msx1/2. Absence 
of implantation sites in mice lacking Msx1/2 following administration of Chicago blue dye 
indicates implantation failure. Histological analyses of uterine sections show that in absence of 
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Msx1/2, the embryos fail to attach to the epithelium indicating a defect in uterine receptivity. 
Further analysis revealed an enhanced estrogen signaling, failure of microvilli flattening and 
sustained epithelial cell polarity in epithelium of Msx1/2 deleted uteri. These alterations 
culminate in severe impairment of epithelial cell function and lack of uterine receptivity. 
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2.3 MATERIALS AND METHODS 
 
Animals 
Mice were maintained in the designated animal care facility at the College of Veterinary 
Medicine of the University of Illinois, Urbana-Champaign, according to the institutional 
guidelines for the care and use of laboratory animals. To generate the conditional Msx1Msx2-null 
mice (Msx1
d/d
Msx2
d/d
), Msx1Msx2-floxed (Msx1
f/f
Msx2
f/f
) [210] mice were mated with PR-Cre 
knock-in mice [211].
  
For breeding studies, cycling Msx1
d/d
Msx2
d/d
 and Msx1
f/f
Msx2
f/f
 female
 
mice were housed with wild-type C57BL/6 male mice (Charles Rivers) for 6 months.
 
The 
presence of a vaginal plug after mating was designated as
 
day 1 of pregnancy. The number of 
litters and pups born were recorded at birth to assess the fertility status. 
 
To induce superovulation, 3-week old female mice were administered intraperitoneally with 5 IU 
of pregnant mare serum gonadotrophin (PMSG, Sigma St.
 
Louis, MO) followed by 5 IU of 
human chorionic gonadotropin (hCG, Sigma St.
 
Louis, MO) 48 hours later. The mice were killed 
16–18 hours post-hCG administration to flush the oviducts and the oocytes were recovered and 
counted. To collect blastocysts, 8-week old female mice were mated with wild-type males. To 
assess the pre- implantation development of embryos, blastocysts were flushed from day 4 
pregnant uteri and examined under a stereo-zoom microscope.  
 
Transmission electron microscopy 
Uterine tissues isolated from Msx1
f/f
Msx2
f/f
 and Msx1
d/d
Msx2
d/d
 female mice on day 4 of 
pregnancy were fixed in 2.0 % paraformaldehyde and 2.5% glutaraldehyde in buffer containing 
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0.1 M sodium cacodylate. Tissues were then washed and fixed with 1.0% aqueous osmium 
tetroxide in 0.1 M sodium cacodylate buffer. Following dehydration with ethanol and propylene 
oxide, the tissues were embedded in 100% Polybed 812 mixture. Sections (80 nm) were cut with 
an Ultramicrotome, stained and examined under a Philips CM 200 Transmission Electron 
Microscope. 
 
Quantitative real time PCR analysis (qPCR) 
Uterine tissue was homogenized and total RNA was extracted by using TRIZOL reagent, 
according to the manufacturer’s protocol. cDNA was prepared by standard protocols. The cDNA 
was amplified by quantitative
 
PCR using gene-specific primers
 
and SYBR Green (Applied 
Biosystems, Warringtom, UK). The expression level of 36B4 or cytokeratin 18 (Ck18) was used 
as the internal control. For each
 
treatment, the mean Ct and standard deviation were calculated
 
from individual Ct values obtained from three replicates
 
of a sample. The normalized Ct in 
each sample was calculated as mean Ct of target gene subtracted by the mean Ct of internal 
control gene. 
 
Ct was then calculated as the difference between the Ct values
 
of the control 
and treatment sample. The fold change of gene expression in each sample relative to a control 
was computed as 2
– Ct
. The mean fold induction and standard errors were calculated from 
three or more independent experiments. 
 
Immunohistochemistry  
Uterine tissues
 
were processed and subjected to immunohistochemistry as described previously 
[212]. Briefly, paraffin-embedded tissues were sectioned at 5 μm and mounted on microscopic 
slides. Sections were deparaffinized in xylene, rehydrated through a series of ethanol washes, 
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and rinsed in water. Antigen retrieval was performed by immersing the slides in 0.1M citrate 
buffer solution, pH 6.0, followed by heating in the microwave for 25 min. The slides were 
allowed to cool and endogenous peroxidase activity was blocked by incubating sections in 0.3% 
hydrogen peroxide in methanol for 15 min at room temperature.  After washing with PBS for 15 
min and the slides were incubated in a blocking solution for 1 h before incubating them in 
primary antibody overnight at 4°C with antibodies specific for MSX1 (Abcam, ab73883), MSX2 
(Santa Cruz, sc-15396), MUC1 (Novus biological, NB120-15481), ESR1 (Santa Cruz, sc-7207), 
p-ESR1 (Santa Cruz, sc-12915), PGR (Neomarkers MS-194-PO) and E-Cadherin (Santa Cruz, 
sc-7870). The slides were incubated with the biotinylated secondary antibodies at room 
temperature for 1h, followed by incubation with horseradish peroxidase-conjugated
 
streptavidin 
(Invitrogen Corp., MD 21704). The sections were stained
 
in 3-amino-9-ethylcarbazole 
chromogen (AEC) solution
 
until optimal signal was developed. Sections were counterstained 
with Mayer’s Hematoxylin and examined by bright field microscopy.  
 
Measurement of serum E and P levels 
The levels of E and P in the serum were measured by radioimmunoassay (RIA) performed at the 
Ligand Core facility of the University of Virginia at Charlottesville.  
 
Statistical Analysis 
Statistical analysis was performed
 
by t-test or ANOVA. The values were expressed as mean ± 
SEM and considered
 
significant if p < 0.05. 
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2.4 RESULTS 
 
Msx1 and Msx2 are expressed in the pre-implantation uterus  
The spatio-temporal profiles of mRNAs and proteins corresponding to Msx1 and Msx2 were 
examined in the mouse uterus during the pre-implantation phase by real-time PCR and 
immunohistochemistry (IHC), respectively. The expression of both Msx1 and Msx2 mRNAs 
followed a similar pattern: a marked increase on days 2-3 of pregnancy followed by a sharp 
decline on day 4 at the time of embryo implantation (Fig.1A, left panel; Fig.1B, left panel). Both 
MSX1 and MSX2 proteins were abundantly expressed in uterine epithelium on day 1 of 
pregnancy (Fig.1A, panel a; Fig.1B, panel a). The expression of these proteins increased further 
on days 2 and 3 of pregnancy and was localized to both glandular epithelium and stroma 
(Fig.1A, panels b and c; Fig.1B, panels b and c). The expression of MSX1 and MSX2 proteins 
then declined on day 4 at the time of embryo implantation and was undetectable on day 5 
(Fig.1A, panels d & e; Fig.1B, panels d & e). Therefore, overlapping expression of Msx1 and 
Msx2 was observed in the uterine epithelial and stromal compartments in the pre-implantation 
phase (Fig. 1C and Table 2). 
 
Hormonal regulation of Msx1 and Msx2 in mouse uterus 
The regulation of Msx1 and Msx2 by ovarian steroids estrogen and progesterone appears to be 
complex. The levels of Msx1 or Msx2 were not induced in the uteri of ovariectomized mice in 
response to estrogen and/or progesterone. On the other hand their levels were reduced in 
response to hormones when compared to oil-treated control uteri. Further, Msx1 level was 
markedly reduced in response to estrogen and Msx2 level was significantly reduced in response 
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to progesterone (Fig. 2A, upper panel; 2B, upper panel). Consistent with the RNA profile, 
immunohistochemical analysis revealed prominent expression of Msx1 and Msx2 in both luminal 
and glandular epithelium of ovariectomized oil-treated uteri. The expression of these proteins 
declined in response to hormones (Fig. 2A, lower panel; 2B, lower panel) indicating that the 
uterine expression of Msx homeobox genes is negatively regulated by ovarian steroids. The 
factors involved in upregulation of Msx genes remain currently unknown.  
 
Ablation of Msx1 and Msx2 in the uterus leads to infertility  
To investigate the function of Msx1 and Msx2 in the uterus, we employed the Cre-LoxP strategy 
to create conditional single knockout of Msx1 or Msx2 or double knockout of Msx1 and Msx2 in 
the uteri of adult mice. Transgenic mice expressing Cre under the control of progesterone 
receptor (PR) promoter were previously used to ablate “floxed” genes selectively in cells 
expressing PR, including uterine cells [52,53,54,120,123]. We, therefore, crossed the PR-Cre 
mice with mice harboring the “floxed” Msx1 or Msx2 or both to create Msx1d/d, Msx2d/d or 
Msx1
d/d
Msx2
d/d
 mice. We confirmed the deletion of Msx1 or Msx2 in the uteri of these mutant 
mice by real-time PCR and IHC. As shown in Fig.3, neither Msx1/Msx2 mRNA nor 
MSX1/MSX2 protein was detected in uteri of Msx1
d/d
Msx2
d/d
 mice on day 3 of pregnancy, 
confirming successful abrogation of both Msx genes in uteri of Msx1
d/d
Msx2
d/d
 mice. A six-
month breeding study demonstrated that the single mutant females, Msx1
d/d
 and Msx2
d/d
, are sub-
fertile but the double mutant females, Msx1
d/d
Msx2
d/d
, are completely infertile (Table 3). While 
Msx1
f/f
Msx2
f/f
 mice exhibited normal litter size and pregnancy rates, the Msx1
d/d
Msx2
d/d
 females 
failed to become pregnant when mated
 
with wild-type males. However, copulatory plugs were 
observed upon mating, indicating normal mating behavior.  
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Ovarian functions and pre-implantation events remain unaffected in Msx1
d/d
Msx2
d/d
 mice  
To investigate the cause of infertility in Msx1
d/d
Msx2
d/d
 females, we examined their ovarian 
functions by inducing superovulation.  Pre-pubertal Msx1
 f/f
Msx2
f/f
 and Msx1
d/d
Msx2
d/d
 mice were 
treated with a regimen of gonadotropin hormones as described in materials and methods. We 
observed that, upon gonadotropin stimulation, the number of eggs produced by Msx1
d/d
Msx2
d/d
 
was comparable to that produced by the Msx1
f/f
Msx2
f/f
 females (Fig.4A), indicating that ovulation 
is not affected in the absence of Msx1 and Msx2. To further examine the ovulation and 
fertilization in these mice under normal physiological conditions, blastocysts were recovered 
from uteri of Msx1
f/f
Msx2
f/f
 and Msx1
d/d
Msx2
d/d
 mice on day 4 of pregnancy prior to implantation. 
Once again, no significant difference was found in either the number or the morphology of the 
embryos recovered from Msx1
f/f
Msx2
f/f
 and Msx1
d/d
Msx2
d/d
 uteri (Figs.4B and 3C). In further 
support of normal ovarian activity, the serum levels of estrogen and progesterone were 
comparable in Msx1
 f/f
Msx2
f/f
 and Msx1
d/d
Msx2
d/d
 females on day 4 of pregnancy (Figs.4D and E).  
Collectively, these results suggested that the infertility of Msx1
d/d
Msx2
d/d
 females is not due to 
impairment
 
in the hypothalamic-pituitary-ovarian axis or lack of fertilization, but is likely due to 
defective implantation or pregnancy failure following implantation. 
 
Ablation of Msx1 and Msx2 in the uterus affects embryo attachment to the luminal 
epithelium 
In mice, the attachment of the embryos to the uterine wall initiates the process of implantation. 
This is accompanied by increased vascular permeability at the implantation sites, which can be 
scored visually as distinct blue bands following an intravenous injection of Chicago blue dye 
[212]. As shown in Fig.5A, Msx1
f/f
Msx2
f/f
 mice displayed distinct implantation sites on day 5 of 
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pregnancy. In contrast, the Msx1
d/d
Msx2
d/d
 females did not show any sign of implantation. 
Implanted embryos were also assessed on days 6 and 7 of pregnancy by visual inspection. Our 
results indicated that implantation sites are absent in Msx1
d/d
Msx2
d/d
 uteri (Fig.5A). 
 
Histological analysis of Msx1
f/f
Msx2
f/f
 females on day 5 of pregnancy showed, as expected, a 
close contact of embryonic trophectoderm with uterine luminal epithelium (Fig.5B, panel a). In 
contrast, in Msx1
d/d
Msx2
d/d
 uteri, embryos did not attach to luminal epithelium. Instead, 
blastocysts remained free-floating in the lumen and were readily recovered by uterine flushing of 
the Msx1
d/d
Msx2
d/d
 females (Fig.5B, panel b). Taken together, these results indicated that the loss 
of Msx1 and Msx2 expression in the uterus resulted in the inability of the luminal epithelium to 
acquire competency for embryo implantation.  
 
Estrogen receptor activity is elevated in uterine epithelium of Msx1
d/d
Msx2
d/d
 mice at the 
time of implantation 
In mice, the window of uterine receptivity is critically regulated by the steroid hormones 17α-
estradiol (E) and progesterone (P), acting through their cognate nuclear receptors. We therefore 
examined the expression levels of progesterone receptor (PGR), estrogen receptor alpha (ESR1), 
and their downstream genes in the uteri of Msx1
d/d
Msx2
d/d
 mice by immunohistochemistry and 
real-time PCR analyses. As shown in Fig.6A, the expression levels of PGR (top panel) and ESR1 
(middle panel) proteins in the luminal epithelium or stromal compartment of Msx1
d/d
Msx2
d/d
 uteri 
were comparable to those of Msx1
f/f
Msx2
f/f
 controls. However, we noted that the expression of 
the transcriptionally active form of ESR1, phosphorylated at serine 118 [213], was markedly up-
regulated in the luminal epithelial cells of Msx1
d/d
Msx2
d/d
 uteri, indicating that ER activity is 
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elevated in the uterine epithelia of these mice (lower panel). This observation indicated that the 
pathways directed by Msx1/Msx2 play an important role in controlling the ESR1 activity, which 
is normally suppressed in uterine epithelium during the receptive phase [61,214,215]. Consistent 
with this up-regulation of transcriptional activity of ESR1, expression of mRNAs corresponding 
to well-known E-regulated genes, such as lactotransferrin (Ltf) [216], chloride channel, calcium 
activated, family member 3 (Clca3) [217], lipocalin 2 [218] and mucin 1 (Muc-1) [114], was 
significantly elevated in uterine epithelium of Msx1
d/d
Msx2
d/d
 uteri on day 4 of pregnancy 
(Fig.6B). 
 
Progesterone signaling is not altered in Msx1
d/d
Msx2
d/d
 mice uteri 
The expression of Ihh, a P-responsive gene in uterine epithelium [52] remained unaltered in 
Msx1
d/d
Msx2
d/d
 uteri. Additionally, the mRNA levels of Hand2 [54] and Hoxa10 [118] , well-
known P-regulated genes in uterine stroma, and that of chicken ovalbumin upstream promoter-
transcription factor II (COUP-TF II), a downstream target of IHH in the uterine stroma [53], 
were unaffected in the uteri of Msx1
d/d
Msx2
d/d
 mice (Fig.7). These results indicated that the loss 
of Msx1 and Msx2 did not have any impact on the transcriptional activity of PGR.  
 
Lack of uterine receptivity in Msx1
d/d
Msx2
d/d
 mice 
The membrane transformation of uterine epithelium at the time of implantation is an important 
parameter of receptive uterus. The presence of long microvilli, containing a thick layer of 
glycoprotein known as the glycocalyx, on the uterine epithelium is indicative of the non- 
receptive stage. A marked flattening of these microvilli occurs in the receptive phase prior to 
implantation [37]. Transmission electron microscopy (TEM) revealed that, in contrast to the 
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control epithelium, the epithelia of Msx1
d/d
Msx2
d/d
 uteri fail to undergo appropriate remodeling to 
promote microvilli flattening, indicating impaired uterine receptivity in these mice (Fig.8A). 
The impaired functional state of uterine epithelium in Msx1
d/d
Msx2
d/d
 mice was also confirmed 
when we analyzed the expression of MUC-1 protein, a major component of the endometrial 
glycocalyx, during early pregnancy. The expression status of MUC-1 is considered an important 
indicator of uterine receptivity [114]. As the luminal epithelium differentiates and the uterus 
achieves receptivity, MUC-1 expression is down regulated in this tissue. Persistent MUC-1 
expression is indicative of a non-receptive uterus, which is not conducive to embryo 
implantation. As shown in Fig.8B, prominent expression of MUC-1 was detected in the uterine 
epithelia of control Msx1
f/f
Msx2
f/f
 mice on day 1 of pregnancy (panel a). As the pregnancy 
advanced to days 4 (panel b) and 5 (panel c), Muc-1 was progressively down regulated in uterine 
epithelia of these mice, consistent with the attainment of receptive status. In contrast, an intense 
expression of MUC-1 was observed in uteri of Msx1
d/d
Msx2
d/d
 mice on days 4 and 5 (panels d–f). 
This elevated epithelial ESR1 signaling is likely involved in the persistent expression of MUC-1 
in luminal epithelium. This in turn disrupted uterine receptivity resulting in implantation failure 
in Msx1
d/d
Msx2
d/d
 mice. 
 
Sustained epithelial cell polarity in Msx1
d/d
Msx2
d/d 
mice 
The uterine epithelium will lose its polarity when it transforms from pre-receptive to receptive 
status. The polarity of the uterine luminal epithelial cells is believed to be maintained by various 
cell-cell junctional complexes including adherens junctions. The family of calcium dependent 
cell–cell adhesion molecule, E-cadherin, is expressed at the adherence junctions during pre-
receptive period; however, its level is dramatically down regulated during uterine receptivity 
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[41,42]. The expression of E-cadherin was elevated in the uterine epithelia of Msx1
d/d
Msx2
d/d
 
mice when compared to control Msx1
f/f
Msx2
f/f
 mice on day 4 of pregnancy indicating sustained 
epithelial cell polarity (Fig.9).  
 
Functional redundancy of Msx1 and Msx2 during uterine receptivity 
The functional redundancy of Msx1 and Msx2 is well known during embryonic development. 
This is not unexpected because of their overlapping expression pattern [162,164,167]. Similarly, 
in the adult uterus Msx1 and Msx2 are expressed in the same cellular compartments during the 
reproductive cycle and early pregnancy. Thus deletion of either Msx1 or Msx2 compensates for 
the loss of the other member and renders mice sub-fertile, while deletion of both Msx1 and Msx2 
leads to infertility. Interestingly we observed that the expression of Msx2 is markedly elevated in 
Msx1-null uterus in the receptive phase (Fig.10A). In contrast the expression of Msx1 is not 
elevated in Msx2-null uterus in the receptive phase (Fig.10B). This indicates that Msx1 might be 
the dominant contributor of uterine receptivity during early pregnancy.  
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2.5 DISCUSSION 
 
The uterine receptivity is a critical step during embryo implantation process and alterations to 
this step causes infertility [6]. Assisted reproductive technologies including in vitro fertilization 
(IVF) are the most commonly sought medical procedures to treat infertility [15]. However, the 
average implantation rate in IVF is only ~25% [16]. The recurrent implantation failure (RIF) is a 
major attributed factor for this reduced success rate [17,18,19]. The RIF could be due to altered 
receptive status of the endometrium which is responsible for approximately two-thirds of 
implantation failures [21], whereas the embryo itself is responsible for only one-third of these 
failures [12,22]. Hence to increase the success rate of IVF, it is important to understand the 
molecular basis of uterine receptivity. The present study demonstrates the expression of Msx1 
and Msx2 in adult uterus and addresses, for the first time, their roles in uterine receptivity. 
 
Using mutant mouse models harboring conditional deletions of Msx1 and/or Msx2 in the uterus, 
we established that these factors play critical roles in regulating uterine function during 
implantation. The deletion of both Msx1/2 renders the mice completely infertile. The ovarian 
functions and preimplantation embryo development are not affected upon deletion of Msx1/2. 
This indicates that the infertility phenotype is intrinsic to uterus. The lack of implantation sites in 
mice lacking Msx1/2 following administration of Chicago blue dye indicates implantation 
failure. Histological analyses of uterine sections show that in the absence of Msx1/2, the embryos 
fail to attach to the epithelium indicating a defect in uterine receptivity.  
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Uterine receptivity is critically regulated by ER and PR. Though the progesterone signaling is 
not altered in uterus lacking Msx1/2, estrogen signaling is greatly altered. The expression of the 
transcriptionally active form of ESR1, phosphorylated at serine 118 [213], was markedly up-
regulated in the luminal epithelial cells of Msx1
d/d
Msx2
d/d
 uteri. It is well established that this 
phosphorylation event is critical for the transcriptional activation of ESR1 [213]. An elevated 
ERα signaling in the epithelium is, however, detrimental to the implantation process. For 
example, ERα promotes the expression of Muc-1, a well-known cell surface glycoprotein, which 
creates a barrier that prevents embryo attachment. In mice, high levels of MUC-1 are present in 
the non-receptive uterus on days 1 and 2 of pregnancy. As the pregnancy progresses, MUC-1 
expression declines in the epithelium and it is drastically reduced on day 4 at the time of 
implantation [114]. Therefore, the reduction of MUC-1 expression is considered a sign of uterine 
receptivity in mice. The persistence of high levels of MUC-1 in the Msx1
d/d
Msx2
d/d
 uteri on day 4 
of pregnancy is indicative of hyperestrogenic activity in the luminal epithelium and 
consequently, reflects a lack of uterine receptivity.  
 
Another important parameter of receptive uterus is the membrane transformation of uterine 
epithelium at the time of implantation. The presence of long microvilli, containing a thick layer 
of glycoprotein known as the glycocalyx, on the uterine epithelium is indicative of the non-
receptive stage. A marked flattening of these microvilli occurs in the receptive phase prior to 
implantation [37]. Transmission electron microscopy (TEM) revealed that, in contrast to the 
control epithelium, the epithelia of Msx1
d/d
Msx2
d/d
 uteri fail to undergo appropriate remodeling to 
promote microvilli flattening, indicating impaired uterine receptivity in these mice. In addition to 
microvilli remodeling, the epithelium undergoes characteristic ultrastructural changes in its 
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polarity. During pre-receptive phase, the epithelium maintains its polarity through different cell 
junctional complexes. The well known marker of epithelium, E-cadherin, is calcium dependent 
molecule expressed abundantly in adherens junctions during pre-receptive period; however, its 
expression level is drastically reduced during receptive period [41]. The elevated level of E-
cadherin in the Msx1
d/d
Msx2
d/d
 uteri on day 4 of pregnancy is indicative of persistent epithelial 
cell polarity, a characteristic feature of nonreceptive uterus.  
 
In summary, the deletion of both Msx1 and Msx2 leads to infertility due to lack of uterine 
receptivity during embryo implantation. The lack of uterine receptivity was characterized by 
enhanced estrogen signaling, failure of microvilli remodeling and sustained epithelial cell 
polarity. In addition, we also observed that the uterine epithelium lacking Msx1/2 exhibited 
persistent proliferation. A detailed analysis of the proliferation defect, which led to the 
identification of the mechanism of action of Msx homeobox genes in mouse uterus, is discussed 
in detail in the next chapter. 
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Figure 1 (Contd.) Expression of Msx1 and Msx2 in the uterus during early pregnancy 
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Figure 1 (Contd.) Expression of Msx1 and Msx2 in the uterus during early pregnancy 
Real-time PCR was performed to monitor the expression of mRNAs corresponding to Msx1 (A,Upper 
panel) and Msx2 (B, Upper panel) in uterus on days 1 to 5 of gestation. The relative levels of gene 
expression on different days of pregnancy were determined by setting the expression level of Msx1 
mRNA on day 1 of pregnancy at 1.0. Rplp0, encoding a ribosomal protein, was used to normalize the 
level of RNA (* p < 0.05). Uterine sections from day 1 to day 5 (a-e) of pregnancy were subjected to 
immunohistochemical analysis using anti-MSX1 (A, Lower panel) and anti-MSX2 (B, Lower panel) 
antibodies. Panel f shows uterine sections from day 3 pregnant mice treated with non-immune IgG. L, G 
and S indicate luminal epithelium, glandular epithelium and stroma, respectively. C: The graphical 
representation of expression profile of Msx1 and Msx2 in uterus on days 1 to 5 of gestation showing the 
similar expression pattern.  
 
Table 2 The compartment specific expression profile of MSX1 and MSX2 in uterus on days 
1 to 5 of gestation 
 
Protein 
Uterine 
Compartment 
Days of Pregnancy 
1 2 3 4 5 
MSX1 
Epithelium ++ ++ +++ + - 
Stroma - + ++ + - 
MSX2 
Epithelium ++ +++ ++ + - 
Stroma - - ++ ++ + 
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Figure 2 (Contd.) Hormonal regulation of Msx1 and Msx2  
Ovariectomized mice were treated with oil or steroid hormones as described in materials and methods. 
Real-time PCR was performed to monitor the expression of mRNAs corresponding to Msx1 (A,Upper 
panel) and Msx2 (B, Upper panel) in uterus (*p<0.05; **p<0.005). Uterine sections were subjected to 
immunohistochemical analysis using anti-MSX1 (A, Lower panel) and anti-MSX2 (B, Lower panel) 
antibodies. 
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Figure 3 Loss of Msx1 and Msx2 expression in the uterus of Msx1
d/d
Msx2
d/d 
mice  
A. Uterine RNA was purified from Msx1
f/f
Msx2
f/f
 and Msx1
d/d
Msx2
d/d 
mice on day 3 of pregnancy (n=3) 
and analyzed by real-time PCR. Relative levels of Msx1 and Msx2 mRNA expression in uteri of 
Msx1
d/d
Msx2
d/d 
mice are compared to those in Msx1 
f/f
Msx2 
f/f 
control mice.  The data are represented as 
the mean fold induction ± SEM, **p<0.001. B. Uterine sections obtained from day 3 pregnant 
Msx1
f/f
Msx2
f/f 
(left panel) and Msx1
d/d
Msx2
d/d 
(right panel) mice were subjected to immunohistochemical 
analysis. Note the lack of MSX1 (upper panel) and MSX2 (lower panel) immunostaining in the uteri of 
the mutant mice. L, G and S indicate luminal epithelium, glandular epithelium and stroma respectively. 
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      Table 3 Ablation of uterine Msx1 and Msx2 leads to female infertility 
Genotype 
No. of 
animals 
No. of 
Litters 
born 
No. of litters per 
animal 
(Mean ± SEM) 
No. of 
pups 
born 
No. of pups 
per litter 
(Mean ± 
SEM) 
Msx1
f/f
Msx2
f/f
 6 32 5.3±0.2 261 8.1±0.4 
Msx1
d/d
 6 14 2.8±0.8 64 4.5±0.6 
Msx2
d/d
 6 22 3.6±0.6 132 6.0±0.5 
Msx1
d/d
Msx2
d/d
 6 0 0 0 0 
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Figure 4 Ovarian functions and preimplantation events are unaffected in Msx1
d/d
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Figure 4 (Contd.) Ovarian functions and preimplantation events are unaffected in 
Msx1
d/d
Msx2
d/d 
mice 
A. Age-matched prepubertal Msx1
f/f
Msx2
f/f 
(n=7) and Msx1
d/d
Msx2
d/d 
mice (n=6) were subjected to 
superovulation. The oocytes were recovered and counted at 18h after hCG administration (values are 
mean ± SEM). B. Pre-implantation embryos were recovered from uteri of Msx1
f/f
Msx2
f/f 
(n=7) and 
Msx1
d/d
Msx2
d/d 
mice (n=12) in the morning of day 4 of pregnancy, counted (values are mean ± SEM) and 
photographed. C. Representative morphology of blastocysts recovered from uteri of Msx1
f/f
Msx2
f/f 
and 
Msx1
d/d
Msx2
d/d 
mice. D & E: E and P levels in serum of Msx1
f/f
Msx2
f/f 
(n=6) and Msx1
d/d
Msx2
d/d 
(n=10) 
mice on day 4 of pregnancy. Values are represented as means ± SEM.  
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Figure 5 (Contd.) Lack of uterine Msx1 and Msx2 causes implantation failure  
A. Embryo implantation sites were examined in Msx1
f/f
Msx2
f/f 
and Msx1
d/d
Msx2
d/d 
mice by the vascular 
permeability assay, which can be scored as distinct blue bands (red arrows) following an injection of 
Chicago blue dye on day 5 of pregnancy (D5, n=6) or direct eye-visualization of implanted embryo on 
day 6 (D6, n=4) and on day 7 (D7, n=4) of pregnancy. The graph represents the quantification of 
implantation sites in Msx1
f/f
Msx2
f/f 
and Msx1
d/d
Msx2
d/d 
mice on day 5 of pregnancy. B. Failure of embryo 
attachment in Msx1
d/d
Msx2
d/d 
uteri. Histological analysis of uterine sections obtained from Msx1
f/f
Msx2
f/f 
(a) and Msx1
d/d
Msx2
d/d 
(b) mice on day 5 (n=3) of pregnancy by Hematoxylin and Eosin staining. Note the 
intimate contact between embryo and luminal epithelium in Msx1
f/f
Msx2
f/f 
mice and the free floating 
embryo in the uterine lumen of Msx1
d/d
Msx2
d/d 
mice. L and E indicate luminal epithelium and embryo 
respectively. 
50 
 
pERα 
α 
 
PR 
 
ER 
a b 
c d 
e f 
Msx1
f/f
Msx2
f/f
 Msx1
d/d
Msx2
d/d
 
Figure 6 Enhanced ERα activity in the luminal epithelium of Msx1d/dMsx2d/d uteri 
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Figure 6 (Contd.) Enhanced ERα activity in the luminal epithelium of Msx1d/dMsx2d/d uteri 
A. Uterine sections obtained from Msx1
f/f 
Msx2
f/f 
(left panel) and Msx1
d/d
Msx2
d/d 
(right panel) mice on day 
4 of pregnancy were subjected to IHC using antibodies against PGR (top panel, a and b), ESR1 (middle 
panel, c and d) and phospho-ESR1 (lower panel, e and f). B. Real-time PCR was performed to analyze the 
expression of E-regulated genes, lactotransferrin (Ltf), Clca3, lipocalin2 and Muc-1 in uteri of 
Msx1
f/f
Msx2
f/f 
and Msx1
d/d
Msx2
d/d 
mice on day 4 of pregnancy. The level of Ck18 was used as internal 
control to normalize gene expression. The data are represented as the mean fold induction ± SEM, 
*p<0.05.  
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Figure 7 Progesterone signaling is not altered in Msx1
d/d
Msx2
d/d
 mice uteri 
Real-time PCR was performed to analyze the expression of P-regulated genes, Ihh, COUP-TF II, Hand2 
and Hoxa10, in uteri of Msx1
f/f
Msx2
f/f 
and Msx1
d/d
Msx2
d/d 
mice on day 4 of pregnancy. The level of Rplp0 
or Ck18 was used as internal control to normalize gene expression. 
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Figure 8 Lack of uterine receptivity in Msx1
d/d
Msx2
d/d
 mice 
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Figure 8 (Contd.) Lack of uterine receptivity in Msx1
d/d
Msx2
d/d
 mice 
A.  Transmission electron microscopy of uterine sections obtained from Msx1
f/f 
Msx2
f/f 
(left panel, a and b) 
and Msx1
d/d
Msx2
d/d 
(right panel, c and d) mice on day 4 of pregnancy. Panels a and c indicate lower 
magnification (5Kx) and b and d indicate higher magnification (30Kx). B. Immunohistochemical analysis 
of Muc-1 expression in the uterine sections of Msx1
f/f
Msx2
f/f 
(Left panel) and Msx1
d/d
Msx2
d/d 
Right panel) 
mice on day 1 (a and d), day 4 (b and e) and day 5 (c and f) of pregnancy. L indicates luminal epithelium. 
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Figure 9 Sustained epithelial cell polarity in Msx1
d/d
Msx2
d/d
 mice 
The level of E - cadherin was examined in the uterine sections of Msx1
f/f
Msx2
f/f 
(left panel) and 
Msx1
d/d
Msx2
d/d 
(right panel) mice on day 4 of pregnancy by immunohistochemistry. Magnification: upper 
panel: 10x, middle panel: 20x and lower panel: 40x. 
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Figure 10 Functional redundancy of Msx genes during uterine receptivity 
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Figure 10 Functional redundancy of Msx genes during uterine receptivity 
A. Upper Panel: Uterine RNA was purified from Msx1f/f and Msx1d/d mice on day 3 and day 4 of 
pregnancy and analyzed by real-time PCR. Relative levels of Msx2 mRNA expression in uteri of Msx1
d/d 
mice are compared to those in Msx1 
f/f 
control mice. Lower Panel: Uterine sections obtained from day 3 
and day pregnant Msx1
f/f 
(upper panel) and Msx1
d/d 
(lower panel) mice were subjected to 
immunohistochemical analysis to detect MSX2. Note the elevated levels of MSX2 immunostaining in the 
uteri of Msx1
d/d 
mice (*p<0.05; **p<0.005).  
B. Upper Panel: Uterine RNA was purified from Msx2f/f and Msx2d/d mice on day 3 and day 4 of 
pregnancy and analyzed by real-time PCR. Relative levels of Msx1 mRNA expression in uteri of Msx2
d/d 
mice are compared to those in Msx2 
f/f 
control mice. Lower Panel: Uterine sections obtained from day 3 
and day pregnant Msx2
f/f 
(upper panel) and Msx2
d/d 
(lower panel) mice were subjected to 
immunohistochemical analysis to detect MSX1. Note the elevated levels of MSX1 immunostaining in the 
uteri of Msx1
d/d 
mice.  
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CHAPTER III 
 
MSX GENES REGULATE UTERINE RECEPTIVITY BY CONTROLLING 
PARACRINE SIGNALING BETWEEN UTERINE STROMA AND EPITHELIUM 
 
3.1 ABSTRACT 
 
The mammalian Msx homeobox genes, Msx1 and Msx2, encode transcription factors that control 
organogenesis and tissue interactions during embryonic development. Conditional ablation of 
both Msx1 and Msx2 in the uterus resulted in female infertility due to lack of uterine receptivity 
during embryo implantation. In these mutant mice (Msx1
d/d
Msx2
d/d
), the uterine epithelium 
exhibited persistent proliferative activity. Gene expression profiling of uterine epithelium and 
stroma of Msx1
d/d
Msx2
d/d
 mice revealed an elevated expression of several members of the Wnt 
gene family in the pre-implantation uterus. Increased canonical Wnt signaling in the stromal cells 
activated β-catenin, stimulating the production of a subset of fibroblast growth factors (FGFs) in 
these cells. The secreted FGFs acted in a paracrine manner via the FGF receptors in the 
epithelium to promote epithelial proliferation, thereby preventing differentiation of this tissue 
and creating a non-receptive uterus refractory to implantation. Collectively, these findings 
delineate a unique signaling network, involving Msx1/2, Wnts, and FGFs, which operates in the 
uterus at the time of implantation to control the mesenchymal-epithelial dialogue critical for 
successful establishment of pregnancy. 
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3.2 INTRODUCTION 
 
Successful implantation is dependent on a timely progression of a series of biological events 
during which the embryo undergoes functional interactions with the uterus [1,4,90,118]. Various 
tissue compartments within the uterus, including luminal epithelium, glandular epithelium, and 
stroma, undergo sequential proliferation and differentiation as the embryo attaches to the luminal 
epithelium and invades into the stroma. In mice, the luminal and glandular epithelial cells are 
proliferative on days 1 and 2 of pregnancy. As pregnancy proceeds, these cells exit from the cell 
cycle and enter a differentiation program that allows their transition to a receptive state. The 
stromal cells underneath the epithelium begin to proliferate on day 3 and this proliferation 
becomes widespread following embryo attachment to the receptive luminal epithelium on day 4 
of pregnancy [1,4,90,118]. As the embryo invades through the luminal epithelium into the 
stromal compartment, the stromal cells differentiate into secretory decidual cells, which support 
further growth and development of the implanted embryo until placentation ensues [1,4,90,118].  
 
Extensive research over the past decade, using genetically altered mutant mouse models, has 
identified several factors that critically regulate uterine function in the pre-implantation or post-
implantation phases of pregnancy [2,50,52-54,120,123]. However, there is only limited insight 
into the molecular mechanisms and signaling pathways that interconnect the various cellular 
compartments of the uterus to achieve receptivity to embryo implantation. Recent studies in our 
laboratory indicated that a subset of fibroblast growth factors (FGFs) produced by the stromal 
cells act in a paracrine manner to promote luminal epithelial proliferation [54]. The transcription 
factor Hand2 suppresses the production of these FGFs and inhibits luminal epithelial 
61 
 
proliferation at the time of implantation [54]. Studies by Lee et al identified Indian hedgehog 
(IHH) as an epithelial paracrine factor that acts on the stromal cells to regulate their 
differentiation [52]. These studies support the concept that maternal competency for implantation 
is determined by a critical exchange of diffusible signals between the epithelial and stromal 
compartments, allowing transition of these tissues to proper functional states that permit embryo 
attachment and invasion. Identification of epithelial or stromal transcription factors and their 
downstream molecular pathways that control these signals is essential for a clear understanding 
of the molecular basis of implantation.  
 
In the previous chapter, we described in detail the infertility phenotype of mice lacking uterine 
Msx1 and Msx2. In this chapter, we provide the molecular mechanism that explains the cause of 
this infertility in Msx1
d/d
Msx2
d/d
 mice.  Our studies revealed that Msx1 and Msx2 function by 
suppressing the expression of several members of the Wnt family. In Msx1/Msx2-null uterus, 
continued expression of a subset of WNTs enhances β-catenin signaling in the stroma, which in 
turn induces the expression of specific members of the fibroblast growth factor (FGF) family in 
this compartment. One or more of these FGFs act via the FGF receptors in the glandular and 
luminal epithelial tissues to promote proliferation and prevent differentiation. Lack of 
differentiation of the glandular epithelial cells results in the failure to express critical factors, 
such as the leukemia inhibitory factor (LIF), which are critical for implantation. This study, 
therefore, delineated a novel signaling network downstream of Msx1 and Msx2, mediating the 
stromal-epithelial crosstalk critical for successful establishment of pregnancy. 
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3.3 MATERIALS AND METHODS 
 
Animals 
Mice were maintained in the designated animal care facility at the College of Veterinary 
Medicine of the University of Illinois, Urbana-Champaign, according to the institutional 
guidelines for the care and use of laboratory animals.  
 
Isolation of uterine epithelial and stromal cells  
Uterine epithelial cells were isolated as previously described [219]. Briefly, uterine horns were 
dissected into 3-4 mm pieces and incubated in a solution of 1% trypsin (Difco, Dertroit, MI) in 
Hank's balanced salt solution (HBSS) for 90 min at 4
0
C and then for 30 min at room 
temperature. The tissues were then rinsed with 10% FBS. Under a dissecting microscope, each 
enzyme treated piece of uterus was squeezed by forceps to separate the epithelium from the rest 
of the uterine tissue. Uterine stromal cells were isolated as previously described [121]. Briefly, 
uterine horns of pregnant mice were dissected and placed in HBSS containing 6 g/liter dispase 
and 25g/liter pancreatin for 1 h at room temperature and then 15 min at 37°C to remove the 
endometrial epithelial clumps. The tissues were then placed in HBSS containing 0.5 g/liter 
collagenase for 45 min at 37 °C to disperse the stromal cells. After vortexing, the contents were 
passed through a 70-μm gauze filter (Millipore). The filtrate contained the stromal cells.  
 
Culture of uterine stromal cells  
The uterine stromal cells were diluted in Dulbecco's modified Eagle's Medium-F12 medium 
(DMEM-F12; with 100 unit/liter penicillin, 0.1 g/liter streptomycin, 1.25 mg/liter Fungizone) 
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with 2% heat-inactivated fetal calf serum. The live cells were counted by trypan blue staining 
using a hemocytometer. Cells were then seeded in 6-well cell culture plates. The unattached cells 
were removed by washing several times with HBSS after 2 h, and cell culture was continued 
after addition of fresh medium supplemented with P (1 μm) and E (10 nm).  
 
Quantitative real time PCR analysis (qPCR) 
Uterine tissue was homogenized and total RNA was extracted by using TRIZOL reagent, 
according to the manufacturer’s protocol. cDNA was prepared by standard protocols. The cDNA 
was amplified to quantify gene expression by quantitative
 
PCR, using gene-specific primers
 
and 
SYBR Green (Applied Biosystems, Warringtom, UK). The expression level of RPLP0 (36B4) or 
cytokeratin 18 (Ck18) was used as the internal control. For each
 
treatment, the mean Ct and 
standard deviation were calculated
 
from individual Ct values obtained from three replicates
 
of a 
sample. The normalized Ct in each sample was calculated as mean Ct of target gene subtracted 
by the mean Ct of internal control gene. 
 
Ct was then calculated as the difference between the 
Ct values
 
of the control and treatment sample. The fold change of gene expression in each 
sample relative to a control was computed as 2
– Ct
. The mean fold induction and standard 
errors were calculated from three or more independent experiments. 
 
Immunohistochemistry  
Uterine tissues
 
were processed and subjected to immunohistochemistry as described previously 
[212]. Briefly, paraffin-embedded tissues were sectioned at 5 μm and mounted on microscopic 
slides. Sections were deparaffinized in xylene, rehydrated through a series of ethanol washes, 
and rinsed in water. Antigen retrieval was performed by immersing the slides in 0.1M citrate 
64 
 
buffer solution, pH 6.0, followed by microwave heating for 25 min. The slides were allowed to 
cool and endogenous peroxidase activity was blocked by incubating sections in 0.3% hydrogen 
peroxide in methanol for 15 min at room temperature.  After washing with PBS for 15 min and 
the slides were incubated in a blocking solution for 1 h before incubating them in primary 
antibody overnight at 4°C with antibodies specific for MSX1 (Abcam, ab73883), MSX2 (Santa 
Cruz, sc-15396), MUC1 (Novus biological, NB120-15481), Ki67 (BD Pharmingen, 550609), 
HAND2 (Santa Cruz, sc-9409), phospho-FRS2 (R&D systems, AF5126), phospho-ERK1/2 
(Santa Cruz, sc-23759-R), phosphor-AKT (Cell Signaling, 4060s) and active β-catenin (PY489, 
Developmental Studies Hybridoma Bank, Iowa City, IA 52242). The slides were incubated with 
the biotinylated secondary antibodies at room temperature for 1h, followed by incubation with 
horseradish peroxidase-conjugated
 
streptavidin (Invitrogen Corp., MD 21704). The sections were 
stained
 
in 3-amino-9-ethylcarbazole chromogen (AEC) solution
 
until optimal signal was 
developed. Sections were counterstained with Mayer’s Hematoxylin and examined by bright 
field microscopy.  
 
siRNA transfection  
Control (scrambled) siRNA and siRNA targeted to β-catenin (s438) were purchased from 
Ambion Inc. The transfection was performed using SilentFect™ Reagent (Bio-Rad), according 
to the manufacturer’s protocol. The stromal cells were isolated from uteri of Msx1f/fMsx2f/f and 
Msx1
d/d
Msx2
d/d
 mice on day 3 of pregnancy and transfected with siRNA after 5 – 6 h of culture. 
The cells were harvested 24 h following transfection and RNA was isolated. 
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DNA Microarray Analysis 
Uterine epithelial and stromal cells were isolated from Msx1
f/f
Msx2
f/f
 and Msx1
d/d
Msx2
d/d
 mice on 
day 4 of pregnancy. Total RNA was prepared from these cells, and hybridized to Affymetrix 
GeneChip Mouse Genome 430 2.0 array as previously described [50]. They were processed and 
analyzed according to the Affymetrix protocol. 
 
Statistical Analysis 
Statistical analysis was performed
 
by t-test or ANOVA. The values were expressed as mean ± 
SEM and considered
 
significant if p < 0.05. 
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3.4 RESULTS 
 
Persistent proliferation of luminal epithelium in Msx1
d/d
Msx2
d/d
 mouse uterus 
A hallmark of the receptive state of normal pregnant uterus is the cessation of epithelial cell 
proliferation prior to implantation (Fig. 11A) [1,4,90,118,220]. Therefore, in Msx1
f/f
Msx2
f/f
 mice, 
immunostaining of Ki67, a cell proliferation marker, was undetectable in the uterine luminal and 
glandular epithelium on day 4 of pregnancy (Fig.11B, panels a and c). However, uterine sections 
of Msx1
d/d
Msx2
d/d
 mice exhibited robust immunostaining for Ki67 in the luminal and glandular 
epithelia (Fig.11B, panels’ b and d), indicating persistent epithelial cell proliferation on day 4 in 
the absence of Msx1 and Msx2.  
 
Endometrial glandular dysfunction in Msx1
d/d
Msx2
d/d
 mouse uterus 
Previous studies indicated that the ability of the glandular epithelium to undergo differentiation 
and produce factors, including leukemia inhibitory factor (LIF) [44], Foxa2 [80], and Spink3 
[81], is critical for implantation. As shown in Fig.12, the expression of these factors was 
drastically reduced in uteri deficient of Msx1 and Msx2.  
 
Collectively, these findings indicated that persistent proliferation of luminal and glandular 
epithelia results in impaired epithelial transition from a proliferative to a non-proliferative state 
that allows proper differentiation. This impairment is a major contributor to implantation failure 
in Msx1
d/d
Msx2
d/d
 mice.  
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Enhanced WNT/β-catenin signaling in the Msx1d/dMsx2d/d mouse uterus 
To gain insights into the mechanisms underlying the implantation defect of uteri lacking Msx1 
and Msx2, we isolated luminal epithelial and stromal cells from Msx1
f/f
Msx2
f/f
 and 
Msx1
d/d
Msx2
d/d
 uteri on day 4 of pregnancy and performed compartment-specific gene 
expression profiling, using Affymetrix Mouse GeneChip arrays. Interestingly, our study revealed 
up-regulation of WNTs in Msx1
d/d
Msx2
d/d
 uteri compared to Msx1
f/f
Msx2
f/f
 uteri. The microarray 
data (GEO accession #GSE30969) were validated by real-time PCR analysis. In the epithelial 
compartment of Msx1
d/d
Msx2
d/d
 uteri, we observed stimulated expression of mRNAs 
corresponding to several Wnts, including Wnt4, Wnt7a and Wnt7b (Fig.13A).  In the stromal 
cells of Msx1
d/d
Msx2
d/d
 uteri, we observed marked up-regulation of Wnt4 and Wnt5a mRNAs 
(Fig.13B).  
 
We next investigated whether the increased expression of the Wnt ligands in the uteri of 
Msx1
d/d
Msx2
d/d
 mice is translated into increased activation of the Wnt signaling pathway. Wnt 
signals are transduced via the canonical Wnt/β-catenin-dependent pathway (Fig. 13C) or the non-
canonical β-catenin-independent pathways [221-223]. When we examined the expression of 
active β-catenin in uterine sections of Msx1f/fMsx2f/f and Msx1d/dMsx2d/d mice on day 4 of 
pregnancy, we noted comparable levels of nuclear expression of active β-catenin in luminal and 
glandular epithelium in both genotypes (Fig.13D). However, a marked increase in the level of 
nuclear β-catenin was observed in the stromal cells of Msx1Msx2-null uteri, indicating that 
canonical β-catenin signaling is markedly enhanced in the Msx1Msx2-ablated stroma (Fig.13D). 
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Enhanced expression of FGF growth factors in the Msx1
d/d
Msx2
d/d
 uterine stromal cells 
In addition to Wnts, gene expression profiling of stromal cells from Msx1
f/f
Msx2
f/f
 and 
Msx1
d/d
Msx2
d/d
 uteri on day 4 of pregnancy also revealed that the levels of mRNAs encoding 
several members of the FGF family, such as Fgf1, Fgf10, Fgf18 and Fgf21, were elevated as a 
consequence of Msx1 and Msx2 deletion (Fig.14A). However, the mRNA levels of these FGFs 
were not altered in the epithelial cells. The expression of mRNAs corresponding to several other 
FGF family members as well as other growth factors, such as TGFβ, EGF, IGF-1, and HBEGF, 
which are expressed in the uterus during pregnancy, was not significantly altered in the uterine 
stroma of Msx1
d/d
Msx2
d/d
 mice (Fig.14A and 14B).  
 
WNT regulates FGF in the Msx1
d/d
Msx2
d/d
 mouse uterus 
Interestingly, previous studies indicated that the production of FGFs, particularly FGF10 and 
FGF18, is stimulated downstream of canonical Wnt signaling during certain cellular processes, 
such as chick embryo development, bone development and human hepatocellular carcinoma 
[193,195,224], raising the possibility that the enhanced β-catenin signaling seen in uterine 
stromal cells of Msx1
d/d
Msx2
d/d
 mice may drive the increased FGF synthesis in these cells. To 
test this possibility, primary stromal cells were isolated from uteri of Msx1
f/f
Msx2
f/f
 and 
Msx1
d/d
Msx2
d/d
 mice on day 3 of pregnancy and transfected with siRNA targeted specifically to 
the β-catenin mRNA. We observed that treatment with this siRNA resulted in more than 80% 
reduction in β-catenin mRNA expression compared to cells transfected with control (scrambled) 
siRNA (Fig.15). Most importantly, as shown in Fig.15, siRNA-mediated down regulation of β-
catenin in the stromal cells led to a significant reduction in expression of FGF10, FGF18, and 
FGF21. However, the expression of FGF1 remained unaltered in cells treated with β-catenin 
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siRNA. These results indicated that canonical Wnt signaling via β-catenin regulates the 
expression of a specific subset of FGF family members in the uterine stromal cells.  
 
Enhanced FGF receptor (FGFR) signaling in the uterine epithelium of Msx1
d/d
Msx2
d/d
 mice 
We next investigated whether the increased production of FGFs downstream of Wnt signaling 
leads to enhanced FGF receptor (FGFR) signaling in the uteri of Msx1
d/d
Msx2
d/d
 mice. 
Stimulation of the cell surface FGFRs by FGF ligands leads to phosphorylation of specific 
tyrosine residues in a critical docking protein, FGFR substrate 2 (FRS2), which guides the 
assembly of distinct multi-protein complexes, leading to the activation of either MAP kinase or 
AKT signaling cascades (Fig. 16A) [225-227]. We, therefore, investigated the state of activation 
of the FGFR signaling pathway in the uteri of Msx1
f/f
Msx2
f/f
 and Msx1
d/d
Msx2
d/d
 mice by 
monitoring the level of phospho-FRS2. We observed only low level of phospho-FRS2 in the 
uterine luminal or glandular epithelium or stroma of Msx1
f/f
Msx2
f/f
 mice on day 4 of pregnancy 
(Fig.16B, panels a-c). In contrast, a marked elevation in the level of phospho-FRS2 was observed 
specifically in the luminal and glandular epithelium, but not in the stroma (Fig.16B, panels d-f) 
of Msx1Msx2-null uteri, indicating that FGFR signaling is increased in uterine epithelium in the 
absence of Msx1/Msx2. Since the FGFs are produced in the stroma of these mutant uteri, this 
finding suggests that they act in a paracrine fashion via the FGFRs on the epithelial cells. 
 
The kinases ERK1/2 and/or PI3K/AKT are known to be activated downstream of FGF receptor 
signaling [225]. We, therefore, investigated whether these pathways were activated in the 
epithelia of Msx1Msx2-ablated uteri. As shown in Fig.16C, phospho-ERK1/2 (pERK) was 
undetectable in the uterine epithelium of Msx1
f/f
Msx2
f/f
 mice on day 4 of pregnancy (panels a-c). 
70 
 
However, a dramatic increase in the immunostaining of pERK1/2 was seen in uterine epithelium 
of Msx1Msx2-null mice on day 4 of pregnancy (panels d-f). In contrast, the expression of 
phospho-AKT was undetectable in both of these genotypes (Fig.16D), suggesting that the 
ERK1/2 pathway, rather than the PI3K/AKT pathway, is the key downstream mediator of 
enhanced FGFR signaling in Msx1Msx2-null uteri. 
 
To examine whether the elevated mitogenic activity in the luminal epithelium of Msx1
d/d
Msx2
d/d
 
uteri on day 4 of pregnancy is indeed a result of the enhanced FGF signaling, we administered 
PD173074, a FGFR-specific inhibitor [228], or vehicle into uterine horns of Msx1
d/d
Msx2
d/d
 mice 
in the pre-implantation phase. As shown in Fig.16E, the epithelia of vehicle-treated uterine horns 
of these mice showed strong expression of phospho-FRS2 in on day 4 of pregnancy (panel a). 
Treatment with the FGFR inhibitor led to a marked reduction in the level of phospho-FRS2 in 
the uterine epithelium (Fig.16E, panel b). Concomitant with this down regulation of FGFR 
signaling, we observed a decline in the proliferative activity of Msx1Msx2-null uterine epithelia 
as well as down-regulation of MUC-1 expression (Fig.16E, panels c-f). Collectively, these 
results are consistent with the hypothesis that increased FGF production, downstream of Wnt-β-
catenin pathway in Msx1Msx2-null uterine stroma, stimulates epithelial proliferation by 
activating FGFR-ERK1/2 signaling pathway. The proliferative epithelium fails to undergo 
differentiation, resulting in persistent expression of MUC-1, which acts as a major barrier to 
embryo attachment and implantation.  
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3.5 DISCUSSION 
Msx1 and Msx2 are critical regulators of the receptive state of the uterus during implantation. 
Particularly interesting is the finding that uterine expression of Msx1Msx2 influences the activity 
of β-catenin in the stroma, which in turn regulates epithelial activity during early pregnancy. The 
identity of the factors that function downstream of Msx1Msx2 to regulate stromal-epithelial 
cross-talk during implantation was revealed by compartment-specific gene expression profiling 
of epithelial and stromal cells collected from control and Msx1Msx2-ablated uteri. We found 
that, in the absence of Msx1 and Msx2 in the uterus, the expression of several WNT ligands was 
up-regulated in uterine epithelial and stromal cells. While the expression of WNT4, WNT7a, and 
WNT7b was elevated in the epithelium, that of WNT4 and WNT5a increased in the stroma. With 
the exception of WNT5a, these WNTs are known to signal via the canonical pathway to release 
β-catenin from a complex with GSK3β, leading to its stabilization and nuclear accumulation 
[221,222]. Nuclear β-catenin then associates with TCF/LEF family transcription factors to 
regulate cellular gene expression. Consistent with this scenario, a marked increase in the level of 
active β-catenin was observed in uterine stromal cells of Msx1d/dMsx2d/d uteri, while the active β-
catenin levels remained unaltered in the surface epithelium. Our results indicated that canonical 
Wnt signaling is specifically enhanced in the stromal cells as a consequence of Msx1Msx2 
ablation. How does Msx1Msx2 regulate the WNTs and whether the β-catenin activation in the 
stromal cells is driven by WNTs originating in the epithelium or stroma, is unclear.  
 
An important finding of this paper is that, in addition to WNTs, the expression of several 
members of the FGF family is stimulated in the stromal cells of Msx1
d/d
Msx2
d/d
 uteri. The FGFs 
belong to a large family of growth factors, comprising 23 distinct members [225-227]. We 
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observed that a subset of FGFs, including FGF1, FGF10, FGF18 and FGF21, exhibited marked 
up-regulation in uterine stroma of Msx1
d/d
Msx2
d/d
 mice, indicating that the expression of these 
growth factors are normally suppressed by Msx1/Msx2. Interestingly, previous studies have 
shown that TCF/LEF, activated downstream of WNT-β-catenin signaling in colorectal cancer 
cells, binds to the promoter regions of FGF18 and FGF20 [193,195,229]. Studies have also 
shown that, in the chick embryo, WNT-β-catenin signaling triggered the synthesis of FGF8 and 
FGF10, which control the initiation of limb development [193]. These previous findings 
suggested that WNT-activated β-catenin regulates the expression of a subset of FGFs [193]. In 
the present study, we provide direct evidence that active β-catenin regulates the synthesis of the 
FGFs, particularly FGF10, FGF18, and FGF21, in the stromal cells, uncovering a link between 
the WNT and FGF signaling pathways in the endometrium. The precise mechanism by which 
active β-catenin regulates the expression of these FGFs in uterine stromal cells remains to be 
determined.  
 
The FGFs exert their paracrine responses by binding to FGFRs on the surface of the target cells 
and activating the receptor tyrosine kinase pathway. It is well documented that signaling via 
FGFRs leads to tyrosine phosphorylation of the docking protein FRS2, followed by the 
recruitment of multiple distinct complexes, which results in activation of Ras/ERK/MAP kinase 
and/or PI3 kinase/AKT signaling pathways in a variety of cell types [225,227]. In uteri lacking 
Msx1 and Msx2, the accumulation in the uterine epithelium of phospho-FRS2, a key indicator of 
FGF signaling, indicated activation of FGFR signaling. Bazer and his coworkers have previously 
reported that the FGFRs are activated in ovine uterine epithelia of sheep in response to the 
secretion of FGF7 and FGF10 from the progesterone-primed mesenchyme and proposed that 
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these factors are potential regulators of the maternal-fetal interactions [230,231]. However, in the 
mouse uterus, the expression of FGF10, FGF18, and FGF21 is suppressed during the receptive 
phase of implantation. The expression of these factors is induced in the absence of Msx1 and 
Msx2, and the consequent increase in FGFR signaling is associated with the lack of uterine 
receptivity and implantation failure in Msx1
d/d
Msx2
d/d
 mice.  
 
The central hypothesis of this chapter is that Msx1Msx2 controls uterine receptivity at the time of 
embryo implantation by regulating epithelial function. During normal pregnancy in mice, the 
uterus attains receptive status on day 4 of gestation when the luminal and glandular epithelia 
cease to proliferate and begin to differentiate. Our study suggests that, in the absence of Msx1 
and Msx2, the uterine stroma produces a subset of FGFs, which act via the FGFRs to stimulate 
the ERK1/2 kinase pathway in both luminal and glandular epithelia. As a consequence, the 
uterine epithelia of Msx1
d/d
Msx2
d/d
 mice remain proliferative and fail to undergo transformation 
to the receptive state that allows embryo attachment to initiate implantation. The activation of the 
ERK1/2 pathway in the epithelium also triggers phosphorylation of epithelial ESR1 at serine-
118. It is well established that this phosphorylation event is critical for the transcriptional 
activation of ESR1 [213]. An elevated ERα signaling in the epithelium is, however, detrimental 
to the implantation process.  
 
Pathways downstream of Msx1 and Msx2 also control the synthesis of glandular factors critical 
for uterine receptivity at the time of implantation. While the uterine luminal epithelium is the 
initial site of embryo attachment, the glandular epithelium is an important source of paracrine 
factors required for the establishment and maintenance of pregnancy [76]. As the uterus acquires 
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competency for implantation, the glandular epithelial cells cease to proliferate and undergo 
differentiation to express factors, such as LIF and FOXA2, which are critical for embryo 
implantation [44,80]. Presumably due to enhanced WNT and FGF signaling in Msx1
d/d
Msx2
d/d
 
uteri, the glandular epithelial cells remain proliferative and fail to express LIF and FOXA2. 
Consistent with this hypothesis, a recent study has shown that expression of constitutively active 
β-catenin in mouse endometrium leads to enhanced proliferation and glandular hyperplasia [89].  
 
We recently reported that the transcription factor HAND2 suppresses the production of a subset 
of FGFs, which act in a paracrine manner to stimulate the proliferation of the luminal epithelium 
[54]. Conditional deletion of Hand2 in the uterus also results in the failure of implantation due to 
impaired uterine receptivity caused by increased production of FGFs in the stroma. The uterine 
phenotype of Hand2 deletion is remarkably similar to those of Msx1Msx2 ablation. We, 
therefore, examined whether Hand2 is regulated by Msx1Msx2 or vice versa. Surprisingly, our 
studies showed that the loss of Msx1 or Msx2 or both did not affect Hand2 expression in the 
uterus during implantation (Fig.17). Similarly, Msx1Msx2 expression is unaltered in Hand2–null 
uteri (Fig.18). Furthermore, while Hand2 coordinately suppresses the expression of FGF1, 
FGF2, FGF9 and FGF18, Msx1Msx2 inhibits the expression of FGF1, FGF10, FGF18, and 
FGF21. Although these results suggest that one or more of these FGFs act in a paracrine manner 
through the epithelial FGFRs to promote epithelial cell proliferation, the contribution of each 
these FGFs remain unclear and, therefore, it remains to be determined whether Hand2 and 
Msx1Msx2 function via similar or distinct mechanisms.  
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In summary, we have uncovered a novel mechanism by which Msx1Msx2 regulates epithelial 
function at the time of implantation (Fig. 19). In normal pregnancy, these factors act to repress 
WNT and β-catenin signaling and inhibit FGF synthesis in the uterine stroma, thereby 
attenuating the paracrine mechanisms that promote epithelial proliferation. It is also evident that 
the activation of ERK1/2 kinase pathway downstream of FGFR signaling in the epithelium of 
Msx1Msx2-ablated uteri activates transcriptional function of ESR1, contributing to the non-
receptive status of the uterus. Continued analysis of the mechanisms by which Msx1 and Msx2 
control the WNT-β-catenin-FGF pathway to direct uterine stromal-epithelial communication will 
clarify our understanding of the molecular events that underlie uterine receptivity. 
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Figure 11 Enhanced proliferation in the uterine epithelium of Msx1
d/d
Msx2
d/d
 mice 
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Figure 11 (Contd.) Enhanced proliferation in the uterine epithelium of Msx1
d/d
Msx2
d/d
 mice 
A. Immunohsitochemical localization of Ki67 in the uterine sections of Msx1
f/f
Msx2
f/f 
mice on days 1, 3 
and 4 of pregnancy. L and G indicate luminal epithelium and glandular epithelium respectively.  B. 
Immunohsitochemical localization of Ki67 in the uterine sections of Msx1
f/f
Msx2
f/f 
(n=5) (left panel, a and 
c) and Msx1
d/d
Msx2
d/d 
(n=5) (right panel, b and d) mice on day 4 of pregnancy. Panels a and b indicate 
lower magnification (20x) and c and d indicate higher magnification (40x). L and G indicate luminal 
epithelium and glandular epithelium respectively.  
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Figure 12 Endometrial glandular dysfunction in Msx1
d/d
Msx2
d/d 
mice 
Real-time PCR was performed to analyze the expression of glandular factors, Lif, Foxa2 and Spink3 in 
uteri of Msx1
f/f
Msx2
f/f 
and Msx1
d/d
Msx2
d/d 
mice on day 4 of pregnancy. The level of Ck18 was used as 
internal control to normalize gene expression. The data are represented as the mean fold induction ± 
SEM, ***p<0.0001. 
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Figure 13 Enhanced Wnt/β-catenin signaling in Msx1d/dMsx2d/d mouse uterus 
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Figure 13 (Contd.) Enhanced Wnt/β-catenin signaling in Msx1d/dMsx2d/d mouse uterus 
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Figure 13 (Contd.) Enhanced Wnt/β-catenin signaling in Msx1d/dMsx2d/d mouse uterus 
A. Schematic representation of Wnt/β-catenin signaling pathway B. Real-time PCR was performed to 
analyze the expression of Wnt ligands in uterine epithelial cells of Msx1
f/f
Msx2
f/f 
and Msx1
d/d
Msx2
d/d 
mice 
on day 4 of pregnancy. The level of Ck18 was used as internal control to normalize gene expression. The 
data are represented as the mean fold induction ± SEM, *p<0.01, ***p<0.0001. C. Real-time PCR was 
performed to analyze the expression of Wnt ligands in uterine stromal cells of Msx1
f/f
Msx2
f/f 
and 
Msx1
d/d
Msx2
d/d 
mice on day 4 of pregnancy. The level of Rplp0 was used as internal control to normalize 
gene expression. The data are represented as the mean fold induction ± SEM, *p<0.01, **p<0.001, 
***p<0.0001. D. The level of active β-catenin in uterine sections of Msx1f/fMsx2f/f (left panel) and 
Msx1
d/d
Msx2
d/d 
(right panel) mice on day 4 of pregnancy was analyzed by IHC. (Magnification: a and c: 
10x, b and d: 40x) 
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Figure 14 Enhanced expression of FGFs  in uterine stromal cells of  Msx1
d/d
Msx2
d/d
 mouse  
A. Schematic representation of FGF signaling pathway B. Real-time PCR was performed to analyze the 
expression of Fgf family members in uterine stromal cells of Msx1
f/f
Msx2
f/f 
and Msx1
d/d
Msx2
d/d 
mice on 
day 4 of pregnancy. The level of Rplp0 was used as internal control to normalize gene expression. The 
data are represented as the mean fold induction ± SEM, *p<0.01, **p<0.001, ***p<0.0001. C. Real-time 
PCR was performed to monitor the expression of Egf family of growth factors in the uterine stroma of 
Msx1
f/f 
Msx2
f/f 
and Msx1
d/d
Msx2
d/d 
mice on day 4 of pregnancy.  
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Figure 15 Wnt/β-catenin signaling controls FGF synthesis in uterine stromal cells 
Primary stromal cells were isolated from uteri of Msx1
f/f
Msx2
f/f 
mice on day 3 of pregnancy and 
transfected with siRNA targeted to the β-catenin mRNA. Total RNA was isolated 24 h after transfection 
to analyze the expression of Fgf family members by real-time PCR. The level of Rplp0 was used as an 
internal control to normalize gene expression. The data are represented as the mean fold induction ± 
SEM, *p<0.01, **p<0.001, ***p<0.0001. 
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Figure 16 (Contd.) Enhanced FGFR signaling in the epithelium of Msx1
d/d
Msx2
d/d 
uteri 
A. The schematic representation of FGF-FGFR signaling pathway B. The level of p-FRS2 was examined 
in the uterine sections of Msx1
f/f
Msx2
f/f 
(upper panel) and Msx1
d/d
Msx2
d/d 
(lower panel) mice on day 4 of 
pregnancy by immunohistochemistry. Magnification: a and d: 10x, b and e: 20x, c and f: 40x. C. The 
level of p-ERK was examined in the uterine sections of Msx1
f/f
Msx2
f/f 
(upper panel) and Msx1
d/d
Msx2
d/d 
(lower panel) mice on day 4 of pregnancy by immunohistochemistry. Magnification: a and d: 10x, b and 
e: 20x, c and f: 40x. L, G and S indicate luminal epithelium, glandular epithelium, and stroma 
respectively. D. The level of p-AKT was examined in the uterine sections of Msx1
f/f
Msx2
f/f 
(upper panel) 
and Msx1
d/d
Msx2
d/d 
(lower panel) mice on day 4 of pregnancy by immunohistochemistry. Magnification: a 
and c: 10x, b and d: 40x.  E. FGFR-specific inhibitor PD173074 was applied to one uterine horn of 
Msx1
d/d
Msx2
d/d
 (n=3) mice on day 3 of pregnancy. The other horn served as vehicle-treated control. 
Uterine horns were collected on day 4 morning and sections were subjected to immunohistochemistry to 
detect p-FRS2, Ki67, and Muc-1.  
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Figure 17 Hand2 expression in Msx1
d/d
Msx2
d/d 
uteri 
The level of Hand2 in uterine sections of Msx1
f/f
Msx2
f/f 
(left panel) and Msx1
d/d
Msx2
d/d
 (right panel) mice 
on day 4 of pregnancy was analyzed by IHC (Magnification: upper panel: 20x, lower panel: 40x).  
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Figure 18 Msx1 and Msx2 expression in Hand2
d/d 
uteri 
The levels of MSX1 (upper panel) and MSX2 (lower panel) were examined in the uterine sections of 
Hand2
f/f
 (left panel) and Hand2
d/d
 (right panel) mice on day 3 of pregnancy by IHC. 
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Figure 19 Mechanism of Msx1 and Msx2 action in mouse uterus 
In normal pregnancy, MSX1 and MSX2 act to repress WNT and β-catenin signaling and inhibit FGF 
synthesis in the uterine stroma, thereby suppressing stromal-epithelial cross-talk. In the absence of MSX1 
and MSX2, FGFs are induced, activating the epithelial FGFR-ERK1/2 pathway, and promoting epithelial 
proliferation. Activated ERK1/2 then phosphorylates epithelial ESR1. This triggers transcriptional 
activation of ESR1 and expression of its target genes, such as Muc-1, which prevent the functional 
transformation of the luminal epithelium to receptive state, blocking embryo implantation. 
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CHAPTER IV 
 
MSX HOMEOBOX GENES ACT DOWNSTREAM OF BMP2 TO REGULATE 
UTERINE DECIDUALIZATION IN THE MOUSE AND THE HUMAN 
 
4.1 ABSTRACT 
 
Differentiation of endometrial stromal cells to decidual cells in a process known as 
decidualization is critical for embryo implantation and successful establishment of pregnancy. 
We previously reported that bone morphogenetic protein 2 (BMP2) mediates uterine stromal cell 
differentiation in the mouse and the human. To identify the downstream target(s) of BMP2 
signaling during decidualization, we performed gene expression profiling of mouse uterine 
stromal cells treated with or without recombinant BMP2. Our studies revealed that the 
expressions of Msx homeobox genes, Msx1 and Msx2, were markedly altered in response to 
exogenous BMP2. To investigate their role during decidualization, we created a conditional 
knockout of the Msx1 and Msx2 gene in the uterus of adult mice by employing the Cre-LoxP 
strategy. Our studies revealed that mice lacking Msx1 and Msx2 fail to elicit a decidual response. 
Further analysis indicated that the uterine stromal cells in the absence of Msx1 and Msx2 are able 
to proliferate but fail to undergo terminal differentiation. We also observed that addition of 
BMP2 to human endometrial stromal cell cultures led to a robust enhancement of Msx1 and 
Msx2 expression and stimulated the differentiation process. Attenuation of Msx1 or Msx2 
expression by siRNAs greatly reduced human stromal differentiation in vitro, indicating that it is 
a key mediator of BMP2-induced decidualization in the mouse and the human. 
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4.2 INTRODUCTION 
 
In murine and human pregnancies, embryos implant by attaching to the luminal epithelium and 
invading into the stroma of the endometrium. Under the influence of the steroid hormones, 
estrogen and progesterone, the stromal cells surrounding the implanting embryo undergo a 
remarkable transformation event. This process, known as decidualization, is an essential 
prerequisite for implantation. In mice, decidualization is initiated at the time of embryo 
attachment to the uterine epithelium on day 4.5 of pregnancy. The attachment reaction is 
followed by the proliferation and differentiation of the stromal cells surrounding the implanting 
embryo to form the decidual bed [1,4]. The decidual cells are thought to produce hormones and 
cytokines that are critical for embryo development, secrete factors that control trophoblast 
invasion and serve an immunoregulatory function during pregnancy [118]. The current challenge 
is to understand the complex process by which steroid hormones regulate the formation and 
function of the decidual tissue. To this end, it is critical to identify and characterize the factors 
induced by the maternal hormones that regulate the proliferation and differentiation of uterine 
stromal cells during the decidualization process. 
 
Our previous studies revealed that progesterone induces the synthesis of bone morphogenetic 
protein-2 (BMP2), a member of the TGFβ superfamily in the uterus during decidualization [121]. 
BMPs are well-known mediators of cell differentiation and development in a variety of tissues 
[232-235]. We observed that addition of recombinant BMP2 to primary cultures of stromal cells 
isolated from pregnant mouse uterus markedly accelerated the decidualization program. 
Conversely, siRNA-mediated downregulation of BMP2 expression in these cells efficiently 
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blocked the differentiation process [121]. Consistent with these in vitro results, it was observed 
that mice deficient in uterine BMP2 are infertile and exhibit a severe defect in stromal 
differentiation [120]. We also observed a remarkable induction in the expression of BMP2 in 
human endometrial stromal cells undergoing decidualization in vitro in response to steroid 
hormones and cAMP. Addition of exogenous BMP2 to these cultures stimulated the 
differentiation process indicating an important role for this signaling molecule in the mouse and 
the human endometrium [121].   
 
In this study, we used microarray-based gene expression profiling and identified Msx homeobox 
genes including Msx1 and Msx2 as downstream targets of BMP2 regulation in stromal cells 
undergoing decidualization. Msx homeobox genes are transcription factors that regulate cellular 
proliferation and differentiation during embryonic development [146,147]. Interestingly, Bmp2 
and Msx1/2 are often co-localized during embryonic development at distinct sites including the 
primitive streak, limb bud, myocardium, and the mammary gland [141,167,185,236]. 
Furthermore, BMP-MSX axis is known to regulate a variety of differentiation systems including 
osteoblast differentiation [237-239]. These findings raised the possibility that the MSX factors 
functioning downstream of BMP2 regulate the uterine differentiation program during embryo 
implantation.  
 
Global deletion of Msx1 or Msx2 gene is embryonic lethal, necessitating the development of 
conditional deletion of these genes to study their functions during decidualization. Conditional 
ablation of either Msx1 or Msx2 showed only modest impairment in decidualization, most likely 
due to compensation of the function of one Msx gene by the other. Indeed, in Msx2-null uteri, the 
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level of Msx1 expression in the uterus was markedly elevated and vice versa. On the other hand, 
conditional ablation of both Msx1 and Msx2 in mouse uterus led to a severe defect in 
decidualization. Our studies further showed that in the absence of MSX1 and MSX2, the uterine 
stromal cells are able to proliferate but are not competent to undergo differentiation, indicating 
that MSX factors are key mediators of BMP2-induced decidualization.  
 
Although evolutionarily very different, humans and rodents have a similar hemochorial type of 
placenta and exhibit similarities in terms of hormonal regulation of gene expression in the uterus. 
In preparation for implantation, the human endometrial stromal cells also undergo a 
differentiation process, known as “predecidualization”, during the progesterone-dominated 
secretory phase of the menstrual cycle [118, 240-242]. Our previous studies have shown that 
BMP2 is strongly induced in human endometrial stromal cells during predecidualization. 
Addition of recombinant BMP2 to human stromal cultures greatly enhanced the differentiation 
process as indicated by the expression of decidual biomarkers [121]. In this study we now show 
a marked induction in the expression of Msx1 and Msx2 in response to BMP2 in human 
endometrial stromal cells during decidualization in vitro. More importantly, attenuation of Msx1 
or Msx2 expression by siRNAs greatly reduced stromal differentiation, suggesting that it is a 
candidate mediator of BMP2-induced decidualization in the human. Collectively, our studies 
uncovered a unique conserved pathway involving BMP2 and MSX that mediates stromal 
decidualization in the mouse and the human. 
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4.3 MATERIALS AND METHODS 
 
Materials 
Recombinant human BMP2 was purchased from R&D systems (Minneapolis, MN).  
 
Animals 
Mice were maintained in the designated animal care facility at the College of Veterinary 
Medicine of the University of Illinois, Urbana-Champaign, according to the institutional 
guidelines for the care and use of laboratory animals. To generate the conditional Msx1Msx2-null 
mice (Msx1
d/d
Msx2
d/d
), Msx1Msx2-floxed (Msx1
f/f
Msx2
f/f
) [210] mice were mated with PR-Cre 
knock-in mice [211].
 
The presence of a vaginal plug after mating was designated as
 
day 1 of 
pregnancy. Female mice were killed at various stages of gestation and the uteri collected. 
 
Decidualization was experimentally induced in non-pregnant mice as described previously [123]. 
Ovariectomized mice were injected s/c with 100 ng of E in 0.1 ml of sesame oil for 3 
consecutive days. This was followed by 2 days rest and then daily injections of 6.7 ng and 2 mg 
of P for 3 consecutive days. On day3, one uterine horn was infused with 50 μl oil and the other 
horn was not infused. The administration of E and P was continued for an additional 3 days and 
then killed to collect the uterine tissue. 
 
In some experiments, animals were injected i.p. with bromodeoxyuridine (BrdU) (2 mg/animal; 
BD Pharmingen) 1 h prior to sacrifice. Uteri were collected and fixed in neutral buffered 
formalin prior to immunohistochemistry (IHC) analysis. 
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Our studies involving human endometrial cell cultures and endometrial biopsies adhere to the 
regulations set forth for the protection of human subjects participating in clinical research and are 
approved by the IRBs of Emory University and the University of Illinois. Endometrium samples 
from early proliferative stage of the menstrual cycle were obtained at the Emory University 
Medical Center from fertile volunteers by Pipelle biopsy.
 
 
Isolation and culture of mouse uterine stromal cells  
Uterine stromal cells were isolated as previously described [121]. Briefly, uterine horns of 
pregnant mice were dissected and placed in HBSS containing 6 g/liter dispase and 25g/liter 
pancreatin for 1 h at room temperature and then 15 min at 37°C to remove the endometrial 
epithelial clumps. The tissues were then placed in HBSS containing 0.5 g/liter collagenase for 45 
min at 37 °C to disperse the stromal cells. After vortexing, the contents were passed through a 
70-μm gauze filter (Millipore). The filtrate containing uterine stromal cells were diluted in 
Dulbecco's modified Eagle's Medium-F12 medium (DMEM-F12; with 100 unit/liter penicillin, 
0.1 g/liter streptomycin, 1.25 mg/liter Fungizone) with 2% heat-inactivated fetal calf serum. The 
live cells were counted by trypan blue staining using a hemocytometer. Cells were then seeded in 
6-well cell culture plates. The unattached cells were removed by washing several times with 
HBSS after 2 h, and cell culture was continued after addition of fresh medium supplemented 
with P (1 μm) and E (10 nm).  
 
Culture of human endometrial stromal cells 
Human stromal cells were isolated from endometrial biopsy samples of fertile women. The cells 
were grown in Dulbecco’s modified Eagle’s medium/F-12 medium containing 5%charcoal 
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stripped fetal bovine serum. The cells were treated with a hormone mixture containing 0.5 mM 
8-bromo-cAMP, 1 µM P and 10 nM E.  Cells were harvested at indicated times after addition of 
hormone mixture. The day of hormones and cAMP treatment was designated as day 0. 
 
Quantitative real time PCR analysis (qPCR) 
The total RNA was extracted by using TRIZOL reagent from homogenized uterine tissue or 
cultured cells according to the manufacturer’s protocol. cDNA was prepared by standard 
protocols. The cDNA was amplified to quantify gene expression by quantitative
 
PCR, using 
gene-specific primers
 
and SYBR Green (Applied Biosystems, Warringtom, UK). The expression 
level of RPLP0 (36B4) was used as the internal control. For each
 
treatment, the mean Ct and 
standard deviation were calculated
 
from individual Ct values obtained from three replicates
 
of a 
sample. The normalized Ct in each sample was calculated as mean Ct of target gene subtracted 
by the mean Ct of internal control gene. 
 
Ct was then calculated as the difference between the 
Ct values
 
of the control and treatment sample. The fold change of gene expression in each 
sample relative to a control was computed as 2
– Ct
. The mean fold induction and standard 
errors were calculated from three or more independent experiments. 
 
Immunohistochemistry  
Uterine tissues
 
were processed and subjected to immunohistochemistry as described previously 
[212]. Briefly, paraffin-embedded tissues were sectioned at 5 μm and mounted on microscopic 
slides. Sections were deparaffinized in xylene, rehydrated through a series of ethanol washes, 
and rinsed in water. Antigen retrieval was performed by immersing the slides in 0.1M citrate 
buffer solution, pH 6.0, followed by microwave heating for 25 min. The slides were allowed to 
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cool and endogenous peroxidase activity was blocked by incubating sections in 0.3% hydrogen 
peroxide in methanol for 15 min at room temperature.  After washing with PBS for 15 min and 
the slides were incubated in a blocking solution for 1 h before incubating them in primary 
antibody overnight at 4°C with antibodies specific for mouse-MSX1 (Abcam, ab73883), human–
MSX1 (Aviva systems biology, ARP31396_T100) and MSX2 (Santa Cruz, sc-15396). The slides 
were incubated with the biotinylated secondary antibodies at room temperature for 1h, followed 
by incubation with horseradish peroxidase-conjugated
 
streptavidin (Invitrogen Corp., MD 
21704). The sections were stained
 
in 3-amino-9-ethylcarbazole chromogen (AEC) solution
 
until 
optimal signal was developed. Sections were counterstained with Mayer’s Hematoxylin and 
examined by bright field microscopy.  
 
siRNA transfection  
Control (scrambled) siRNA and siRNA targeted to Msx1 or Msx2 were purchased from Ambion 
Inc. The transfection was performed using SilentFect™ Reagent (Bio-Rad), according to the 
manufacturer’s protocol. The human stromal cells were transfected with siRNA after reaching 
70% confluency. The cells were harvested 24 h following transfection to extract the RNA. 
 
Statistical Analysis 
Statistical analysis was performed
 
by t-test or ANOVA. The values were expressed as mean ± 
SEM and considered
 
significant if p < 0.05. 
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4.4 RESULTS 
 
Msx homeobox genes are downstream targets of BMP2 during decidualization 
Our previous studies have shown that BMP2 plays a critical role in the regulation of stromal 
differentiation during implantation. To determine the function of BMP2 during this 
differentiation process, we employed a primary culture system in which undifferentiated stromal 
cells isolated from pregnant mouse uterus undergo decidualization. When recombinant BMP2 
was added to these stromal cultures, it markedly advanced the differentiation program. To gain 
insight into the mechanisms by which BMP2 regulates decidualization, we performed gene 
expression profiling of RNA isolated from primary stromal culture system treated with or 
without recombinant BMP2 for 24 h. Total RNA was isolated from uterine stromal cells and 
subjected to microarray analysis using Affymetrix murine GeneChip arrays. Interestingly we 
observed that the expression of the homeobox gene Msx1 was downregulated while that of Msx2 
was upregulated in the stromal cells in response to BMP2. We verified the results of the 
microarray analysis by performing real-time PCR analysis. Primary cultures of stromal cells 
isolated from pregnant uteri (preimplantation, day 4) were subjected to decidualization in the 
absence or presence of BMP2. As shown in Fig. 20, a marked increase in the expression of Msx2 
was observed when stromal cells were treated with BMP2. In contrast, the expression of Msx1 
declined signficantly in the BMP2-treated stromal cells. 
 
Expression profile of Msx1 and Msx2 during stromal cell decidualization  
We next examined the expression profile of Msx1 and Msx2 during in vitro stromal cell 
differentiation. As the duration of stromal cell culture progressed from 2 to 72 h, we noted a 
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dramatic decline in the level of Msx1 while a steady enhancement in the expression of Msx2 
(Figs. 21A and 21B, upper panels). Immunocytochemical studies confirmed a similar temporal 
pattern of expression and prominent nuclear localization of Msx1 and Msx2 at 24 h and 72 h of 
decidualization (Figs. 21A and 21B, lower panels) consistent with the possibility that BMP2 
differentially regulates Msx1 and Msx2 expression in the uterus during decidualization.  
 
We next examined the spatio-temporal profiles of mRNAs and proteins corresponding to Msx1 
and Msx2 in the mouse uterus on days 4 to 7 of pregnancy by real-time PCR and 
immunohistochemistry (IHC), respectively. Consistent with the expression profiles of Msx1 and 
Msx2 during in vitro stromal differentiation, we observed a sharp decline in the level of Msx1 on 
day 5 at the onset of stromal differentiation and a marked increase in the level of Msx2 on day 7 
at the time of decidualization (Fig. 22A, upper panel; Fig. 22B, upper panel). Both MSX1 and 
MSX2 proteins were abundantly expressed in uterine epithelium and stroma on day 4 of 
pregnancy (Fig. 22A, lower panel a; Fig. 22B, lower panel a). The expression of MSX1 protein 
then declined on day 5 at the time of embryo implantation and was undetectable on days 5 to 7 
overlapping the decidual phase of pregnancy (Fig. 22A, lower panels b-d). In contrast, we 
detected low but specific nuclear expression of MSX2 in the stromal cells as pregnancy 
progressed to days 5 and 6, the expression of MSX2 then intensified in the decidualizing stromal 
cells surrounding the implanted embryo on day 7 (Fig. 22B, lower panels b-d). These results 
showed that MSX2 is localized specifically in differentiating stromal cells during early 
pregnancy. 
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Ablation of Msx1 and Msx2 in the uterus leads to a defect in decidualization  
To investigate the function of Msx1 and Msx2 in the uterus during decidualization, we employed 
the Cre-LoxP strategy to create conditional single knockout of Msx1 or Msx2 in the uteri of adult 
mice. Transgenic mice expressing Cre under the control of progesterone receptor (PR) promoter 
was previously used to ablate “floxed” genes selectively in cells expressing PR, including uterine 
cells. We, therefore, crossed the PR-Cre mice with mice harboring the “floxed” Msx1 or Msx2 to 
create Msx1
d/d
 or Msx2
d/d
 mice. We confirmed the deletion of Msx1 or Msx2 in the uteri of these 
mutant mice by real-time PCR (Fig. 23A). Interestingly, though, we found that deletion of Msx2 
in Msx2
d/d
 and Msx1 in Msx1
d/d
 mice led to a marked elevation in the expression of Msx1 and 
Msx2 respectively, raising the possibility that function of one Msx gene would likely be 
compensated by the other in single mutants (Fig. 23B).  
 
The effect of Msx1 and Msx2 in uterine decidualization was then investigated in a double 
knockout of Msx1 and Msx2 termed as Msx1
d/d
Msx2
d/d
 mice. Ovariectomized Msx1
f/f
Msx2
f/f
 and 
Msx1
d/d
Msx2
d/d
 mice were treated with a well-established regimen of steroid hormones and then 
decidualization reaction was initiated in one uterine horn by intra luminal injection of oil while 
the other horn was left unstimulated. We then examined the gross anatomy of the stimulated and 
unstimulated uterine horns of Msx1
f/f
Msx2
f/f
 and Msx1
d/d
Msx2
d/d
 mice. As expected, the uterine 
horn of Msx1
f/f
Msx2
f/f
 mice exhibited a robust decidual response at 72 h after receiving the 
artificial stimulation (Fig. 24, upper left panel). In contrast, the Msx1Msx2-deficient uteri under 
identical conditions failed to show any significant decidualization (Fig. 24, upper right panel). 
When the decidual response was assessed by measurement of uterine wet weight gain, the 
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Msx1Msx2-deficient uteri exhibited a markedly reduced weight gain relative to that seen in the 
Msx1
f/f
Msx2
f/f
 uteri (Fig. 24, lower panel). 
 
Stromal proliferation is intact while differentiation is compromised in Msx1Msx2-deficient 
uteri  
During the decidualization phase of pregnancy, the uterine stromal cells undergo proliferation for 
24–48 h and then enter the differentiation program [243, 244]. The lack of decidual response in 
Msx1Msx2-null uteri raised the possibility that Msx1 and Msx2 are potential regulators of 
pathways directing stromal proliferation or differentiation or both. 
 
To analyze the effect of Msx1 and Msx2 on stromal cell proliferation, we subjected Msx1
f/f
Msx2
f/f
 
and Msx1
d/d
Msx2
d/d
 mice to experimentally induced decidualization as described in materials and 
methods and monitored the incorporation of BrdU in uterine stromal cells after decidual 
stimulation. We administered a 1h pulse of BrdU at 23h after the decidual stimulation and 
collected uteri at 24 h. As shown in Fig. 25A, the uterine sections of Msx1
f/f
Msx2
f/f
 and 
Msx1
d/d
Msx2
d/d
 exhibited similar pattern of BrdU immunostaining in the stromal cells indicating 
that Msx1 and Msx2 are not necessary for stromal cell proliferation during decidualization.  
 
We further analyzed the decidualization response of Msx1
d/d
Msx2
d/d
 uteri by monitoring the 
expression of prolactin-related protein (PRP), Wnt4, and connexin 43 (Cx43), factors that are 
induced in stromal cells during decidualization and play important regulatory roles during this 
process [118,122,123]. As shown in Fig. 25B, when Msx1
f/f
Msx2
f/f
 and Msx1Msx2-deficient uteri 
were subjected to artificial decidual stimulation, we observed a marked downregulation of 
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mRNAs corresponding to PRP, Wnt4, and Cx43 in the uteri lacking Msx1Msx2, indicating that 
Msx1 and Msx2 are necessary for stromal cell differentiation. 
 
Expression of MSX1 and MSX2 in human endometrial stromal cells during decidualization 
To assess the phylogenetic conservation and possible clinical significance of these pathways, we 
next investigated the expression of MSX1 and MSX2 in human endometrial stromal cells during 
in vitro decidualization. Undifferentiated stromal cells isolated from human endometrial biopsies 
obtained from normal fertile women in the proliferative stage of the menstrual cycle were placed 
in culture and subjected to decidualization in response to a hormonal cocktail containing P, E, 
and 8-bromo-cAMP [121]. We observed the induction of classical decidualization biomarkers, 
prolactin (PRL) and insulin-like growth factor binding protein 1 (IGFBP1), during this in vitro 
decidualization process (data not shown). When we examined the expression of MSX1 and 
MSX2 mRNA during in vitro decidualization, we observed a marked induction of these genes in 
stromal cells in response to the hormone cocktail at 6 days of initiating the culture (Fig. 26A, 
upper panel, Fig. 26B, upper panel). Consistent with the RNA profile, distinct nuclear staining of 
MSX1 and MSX2 proteins was observed in human endometrial stromal cells with the onset of 
decidualization (Fig. 26A, lower panel, Fig. 26B, lower panel).  
 
Our previous studies have shown that BMP2 is a key mediator of stromal decidualization in the 
human [121]. To further explore the relationship between BMP2 and MSX expression, and to 
test whether this important functional link is conserved among the species, we next investigated 
whether BMP2 regulates the expression of MSX1 and MSX2 in human endometrial stromal cells 
during in vitro decidualization. Human endometrial stromal cells were transduced with an 
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adenovirus expressing BMP2 or GFP (control) and then subjected to decidualization in the 
presence of progesterone, estrogen, and 8-bromo-cAMP. We observed the induction of classical 
decidualization biomarkers, prolactin (PRL) and insulin-like growth factor binding protein 1 
(IGFBP1), and BMP2 downstream targets, WNT4 and SMAD6, in response to exogenous BMP2 
during in vitro decidualization process (Fig. 27).  We also observed a marked increase in the 
level of MSX1 and MSX2 mRNAs and proteins in response to BMP2 (Fig. 27) indicating that 
these homeobox genes are functioning downstream of BMP2 signaling in the human endometrial 
stromal cells during decidualization.  
 
MSX genes regulate decidualization of human endometrial stromal cells 
We next investigated the role of MSX1 and MSX2 in human endometrial stromal cell 
differentiation by employing RNA interference strategy. Primary human endometrial stromal 
cells were transfected with siRNA targeted specifically to the MSX1 or MSX2 mRNA. In control 
experiments, cells were transfected with a scrambled siRNA. As shown in Fig. 28, endometrial 
stromal cells treated with a siRNA targeted to MSX1 mRNA efficiently suppressed the level of 
this mRNA. This specific downregulation of MSX1 expression was associated with a marked 
reduction in the expression of differentiation markers such as IGFBP1 and PRL compared to 
control scrambled siRNA-treated cells. Downregulation of MSX2 expression was also associated 
with a marked reduction in the level of IGFBP1. The expression of GAPDH remained unaltered 
under these conditions. Collectively, these results indicate that MSX1 and MSX2 are important 
mediators of BMP2-induced human stromal cell differentiation. 
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4.5 DISCUSSION 
Decidualization is a critical process in which the fibroblastic stromal cells of the uterus 
proliferate and then differentiate into decidual cells. This steroid-dependent event is 
indispensable for embryo implantation and establishment of a functional maternal-fetal unit 
during early pregnancy. We previously reported the decidual stage-specific expression of BMP2 
and its receptor in the uterine stroma during early pregnancy and provided a potential link 
between BMP2 signaling and the steroid-dependent changes underlying stromal differentiation 
during decidualization. The functional role of BMP2 during embryo implantation was 
demonstrated using transgenic mice carrying a conditional deletion of this gene in mouse uterus. 
BMP2-null mice are infertile due to the absence of a decidual response. Although the embryos 
attach to the uterine epithelium, the stromal cells fail to undergo decidualization. In parallel to 
the creation of the BMP2-null mice, the mouse and human primary stromal cultures were utilized 
to provide novel insights into the role of BMP2 and its downstream signaling pathways in uterine 
decidualization. These studies indicated that BMP2-mediated canonical Smad signaling in the 
uterus plays a critical role in stromal cell differentiation during early pregnancy.  
 
Microarray analyses conducted with endometrial stromal cells treated with exogenous BMP2 
revealed the involvement of Msx1 and Msx2 in BMP2 signaling. Like BMPs, the Msx family of 
homeobox proteins exerts pleiotropic effects including tissue morphogenesis and cell 
differentiation. The present study describes the expression of Msx1 and Msx2 in uterus during 
decidualization and addresses, for the first time, their roles in stromal cell differentiation. Our 
studies revealed a marked induction of Msx2 in mouse endometrial stromal cultures when BMP2 
was added to induce differentiation. In contrast, the expression of Msx1 was downregulated in 
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response to BMP2, suggesting that BMP2 differentially regulates Msx expression in mouse 
uterine stromal cells during decidualization. Interestingly BMP2 was able to promote the 
expression of both Msx1 and Msx2 in human endometrial stromal cells during decidualization. 
While the functional significance of this distinct pattern of Msx1 and Msx2 expression in mouse 
and human endometrium is not known, it is clear that BMP2-Msx pathway is a critical regulator 
of mouse and human decidualization.  
 
BMPs and MSXs are often expressed at the same sites in many tissues including primitive streak, 
lateral mesoderm, limb bud, myocardium, hindbrain and tooth germ during embryonic 
development [141,144,184,185]. The expression of MSX1/2 is induced in response to BMP2/4 
supplementation in tooth mesenchyme explant [186] and in facial primordia [187]. BMP2 
mediates vascular calcification and osteoblastogenesis through the induction of Msx2 [245-247]. 
In chick limb when BMP signaling was inhibited in response to a dominant-negative mutant of 
BMP-receptor, the level of Msx2 transcript declined significantly [248]. The level of endogenous 
Msx2 was markedly reduced in differentiating Smad4
−/−
 ES cells compared to wild-type cells. 
Furthermore based on the reporter assays of the Msx2 promoter in fibroblasts and ES cells, the 
absolute requirement of Smad4 for Msx2 activation was established indicating that Msx2 is a 
direct target of BMP2 signaling [237,249]. While BMP2 has been shown to induce Msx1 in the 
oral epithelium during tooth development [250] and in the explant culture of embryonic lateral 
telencephalic neuroectoderm [251], whether Msx1 is a direct target of BMP2 signaling remains 
unknown. 
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Using mutant mouse models harboring conditional deletion of Msx1 and Msx2 in the uterus, we 
established that these factors play critical roles in stromal cell differentiation during 
decidualization. We observed that the expression of Msx1 is markedly elevated in Msx2-null 
uterus during decidualization, supporting the concept that the loss of function of one Msx gene 
during early pregnancy is partially compensated by the other. Interestingly, mice lacking both 
Msx1 and Msx2 in their uteri show a severe defect in decidual response.  Our studies further 
revealed that deletion of Msx1 and Msx2 did not affect stromal cell proliferation. However, 
stromal cell differentiation, as indicated by the expression of specific markers, was severely 
affected in Msx1
d/d
Msx2
d/d 
uteri. It indicates that Msx1 and Msx2 are not required for stromal cell 
proliferation but they are essential for terminal differentiation. Interestingly, uterine loss of 
BMP2 does not affect stromal cell proliferation but severely compromises differentiation, 
suggesting that Bmp2 mediates stromal cell differentiation through Msx1/2. Whether BMP2 
directly regulates Msx expression in the uterus during decidualization requires further 
investigation. 
 
Another important aspect of this study is its exploration of the role of MSX during 
decidualization of human endometrial stromal cells. Our studies revealed that MSX1 and MSX2 
expression in the human endometrial stromal cells follow that of BMP2 during decidualization. 
Addition of exogenous BMP2 to human stromal cultures further enhanced their levels suggesting 
that BMP2 might mediate endometrial stromal differentiation through MSX1/2. Consistent with 
this notion, we demonstrated that downregulation of MSX1 or MSX2 by loss-of-function 
approaches markedly affected the differentiation program in the human endometrial stromal 
culture. These results indicated that a conserved molecular pathway involving BMP2 and MSX 
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operates during uterine stromal cell differentiation in mice and humans. It is of interest to note 
that unlike BMP2, MSX1/2 proteins are detectable even in the proliferating endometrial stromal 
cells. While the spatio-temporal expression pattern of MSX1/2 during different phases of the 
menstrual cycle in human has not been reported, microarray analysis performed on endometrial 
samples collected during different phases of menstrual cycle revealed that the expression of MSX 
genes were reduced during uterine receptivity. Hence it is tempting to speculate that MSX genes, 
as we have shown previously in mice, might also play a role during uterine receptivity in the 
human. The role of MSX1/2 in human endometrial receptivity needs further investigation.  
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Figure 20 Msx homeobox genes are downstream targets of BMP2 during decidualization 
Stromal cells isolated from day 4 pregnant uteri were cultured for 24h in vitro with or without Bmp2 as 
described in materials and methods. The cells were lysed and real-time PCR was performed to monitor 
the expression of mRNAs corresponding to Msx1 and Msx2. The relative levels of gene expression were 
determined by setting the expression level of Msx1 and Msx2 mRNA in control at 1.0. Rplp0, encoding a 
ribosomal protein, was used to normalize the level of RNA (* p < 0.05). 
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Figure 21 Expression profile of Msx1 and Msx2 during in vitro stromal cell differentiation  
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Figure 21 (Contd.) Expression profile of Msx1 and Msx2 during in vitro stromal cell 
differentiation  
Stromal cells isolated from day 4 pregnant uteri were cultured in vitro as described in materials and 
methods. The cells were lysed at different time points and real-time PCR was performed to monitor the 
expression of mRNAs corresponding to Msx1 (A, Upper panel) and Msx2 (B, Upper panel) (* p < 
0.05; ** p < 0.005). Stromal cells isolated from day 4 pregnant uteri were cultured in vitro as described in 
materials and methods. The cells were fixed at different time points and were subjected 
immunocytochemical staining using anti-Msx1 (A, Lower panel) and anti-Msx2 (B, Lower panel) 
antibodies. 
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Figure 22 Expression of Msx1 and Msx2 in the uterus during early pregnancy 
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Figure 22 (Contd.) Expression of Msx1 and Msx2 in the uterus during early pregnancy 
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Figure 22 (Contd.) Expression of Msx1 and Msx2 in the uterus during early pregnancy 
Real-time PCR was performed to monitor the expression of mRNAs corresponding to Msx1 (A, 
Upper panel) and Msx2 (B, Upper panel) in uterus on days 4 to 7 of gestation. The relative levels 
of gene expression on different days of pregnancy were determined by setting the expression 
level of mRNA on day 4 of pregnancy at 1.0. Rplp0, encoding a ribosomal protein, was used to 
normalize the level of RNA. Uterine sections from day 4 to day 7 (a-d) of pregnancy were 
subjected to immunohistochemical analysis using anti-MSX1 (A, Lower panel) and anti-MSX2 
(B, Lower panel) antibodies. L, G, S and E indicate luminal epithelium, glandular epithelium, 
stroma and embryo, respectively (* p < 0.05; ** p < 0.005). 
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Figure 23 Functional redundancy of Msx1 and Msx2 during uterine decidualization 
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Figure 23 (Contd.) Functional redundancy of Msx1 and Msx2 during uterine 
decidualization 
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Figure 23 (Contd.) Functional redundancy of Msx1 and Msx2 during uterine 
decidualization 
A: Upper panel: Uterine RNA was purified from Msx1
f/f
 and Msx1
d/d 
mice on day 5 of pregnancy and 
analyzed by real-time PCR. Relative levels of Msx1 and Msx2 mRNA expression in uteri of Msx1
d/d 
mice 
are compared to those in Msx1 
f/f 
control mice.  The data are represented as the mean fold induction ± 
SEM (* p < 0.05; ** p < 0.005). Lower panel: Uterine RNA was purified from Msx2
f/f
 and Msx2
d/d 
mice 
on day 6 of pregnancy and analyzed by real-time PCR. Relative levels of Msx2 and Msx1 mRNA 
expression in uteri of Msx2
d/d 
mice are compared to those in Msx2 
f/f 
control mice.  The data are 
represented as the mean fold induction ± SEM (* p < 0.05; ** p < 0.005). 
B: Upper panel: Uterine RNA was purified from Msx2
f/f
 and Msx2
d/d 
mice on day 5, 6 and 7 of pregnancy 
and analyzed by real-time PCR. Relative levels of Msx1 mRNA expression in uteri of Msx2
d/d 
mice are 
compared to those in Msx2 
f/f 
control mice.  The data are represented as the mean fold induction ± SEM (* 
p < 0.05; ** p < 0.005). Lower panel: Uterine RNA was purified from Msx1
f/f
 and Msx1
d/d 
mice on day 5, 
6 and 7 of pregnancy and analyzed by real-time PCR. Relative levels of Msx2 mRNA expression in uteri 
of Msx1
d/d 
mice are compared to those in Msx1 
f/f 
control mice.  The data are represented as the mean fold 
induction ± SEM (* p < 0.05; ** p < 0.005).   
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Figure 24 Ablation of Msx1 and Msx2 in the uterus leads to a defect in decidualization 
Upper panel: Ovariectomized Msx1
f/f
Msx2
f/f
 and Msx1
d/d
Msx2
d/d 
mice were subjected to experimentally 
induced decidualization as described in materials and methods. The stimulated horn is indicated as ‘S’ 
and the unstimulated horn as ‘US’.  Lower panel:  The ratio of uterine wet weight gain between 
stimulated and unstimulated horns from Msx1
f/f
Msx2
f/f
 and Msx1
d/d
Msx2
d/d 
mice. The data are presented as 
mean ± SEM (*** p < 0.0001).  
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Figure 25 Stromal proliferation is intact while differentiation is compromised in 
Msx1Msx2-deficient uteri  
A. Examination of uterine stromal cell proliferation of Msx1
d/d
Msx2
d/d
 mice using BrdU immunostaining. 
Ovariectomized Msx1
f/f
Msx2
f/f
 and Msx1
d/d
Msx2
d/d 
mice were subjected to experimentally induced 
decidualization as described in materials and methods. Mice were given BrdU injection at 23h after the 
infusion of oil and uterine tissues were collected at 24h. The uterine sections were subjected to 
immunohistochemistry using an antibody specific for BrdU. B. Realtime PCR was performed to assess 
the expression levels of Prl8a2, Wnt4 and Gja1 mRNA in the uteri of Msx1
f/f
Msx2
f/f
 and Msx1
d/d
Msx2
d/d 
mice uteri collected 72 h after the infusion of oil (* p < 0.05; ** p < 0.005). 
     Msx1f/fMsx2f/f                                             Msx1d/dMsx2d/d 
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Figure 26 Expression of MSX1 and MSX2 in human endometrial stromal cells during 
decidualization 
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Figure 26 (Contd.) Expression of MSX1 and MSX2 in human endometrial stromal cells 
during decidualization 
The primary cultures of human endometrial stromal cells were performed as described in materials and 
methods. The cells were lysed at different time points as indicated. Total RNA was isolated and real time 
PCR was performed to analyze the levels of MSX1 (A, Upper panel) and MSX2 (B, Upper panel). 
RPLP0, encoding a ribosomal protein, was used to normalize the level of RNA (* p < 0.05; ** p < 0.005). 
Immunocytochemical analysis of MSX1 (A, Lower panel) and MSX2 (B, Lower panel) on day 0 and 
day4 during in vitro stromal cell differentiation. 
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Figure 27 MSX1 and MSX2 mediate BMP2 induced human endometrial stromal cell 
decidualization 
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Figure 27 (Contd.) MSX1 and MSX2 mediate BMP2 induced human endometrial stromal 
cell decidualization 
The primary cultures of human endometrial stromal cells were performed as described in materials and 
methods. The cells were transduced with adenovirus expressing BMP2 or GFP. The cells were lysed at 
different time points as indicated. Total RNA was isolated and real time PCR was performed to analyze 
the levels of IGFBP-1, PRL, WNT4, SMAD6, MSX1 and MSX2. The relative levels of gene expression 
were determined by setting the expression level on day 0 of GFP treated at 1.0. RPLP0, encoding a 
ribosomal protein, was used to normalize the level of RNA (* p < 0.05; ** p < 0.005). 
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Figure 28 MSX genes regulate decidualization of human endometrial stromal cells 
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Figure 28 (Contd.) MSX genes regulate decidualization of human endometrial stromal cells 
The human endometrial stromal cells were transfected with MSX1 siRNA (A) or MSX2 siRNA (B) after 
reaching approximately 70% confluency. The control group was transfected with scrambled siRNA. The 
siRNA was removed after 24 h and the culture was continued for additional 2 days after the addition of 
hormones and cAMP. The cells were lysed to isolate total RNA and real time PCR was performed to 
analyze the levels of MSX1, IGFBP-1 and PRL. The relative levels of gene expression were determined 
by setting the expression level of scrambled siRNA treated at 1.0. RPLP0, encoding a ribosomal protein, 
was used to normalize the level of RNA (* p < 0.05; ** p < 0.005). 
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CHAPTER V 
 
CONCLUSIONS 
 
The present study was designed to understand the role of homeobox transcription factors, Msx1 
and Msx2, in the uterus during embryo implantation. To gain an insight into the function of Msx 
genes in uterus, we generated conditional knockout mice (Msx1
d/d
Msx2
d/d
) by crossing Msx 
floxed mice with progesterone receptor cre mice. Six months breeding studies revealed that the 
mice lacking both Msx1 and Msx2 in their uteri were infertile. Subsequent analysis revealed that 
Msx1
d/d
Msx2
d/d 
mice exhibited normal ovarian functions. While the preimplantation development 
of embryos and their transit into the uterus were normal, Chicago blue dye assay failed to exhibit 
blue bands in the uteri of Msx1
d/d
Msx2
d/d 
mice indicating implantation failure. Histological 
analysis of uterus revealed that the blastocysts failed to attach to the uterine epithelium. 
Ultrastructural analysis of uterine luminal epithelium using transmission electron microscopy 
demonstrated a failure of microvilli remodeling on day 4 of pregnancy. Further, estrogen 
signaling was highly elevated in the uterine luminal epithelium of Msx1
d/d
Msx2
d/d 
mice. The level 
of Muc1 (a marker of uterine receptivity) was greatly enhanced in the uterine luminal epithelium 
of Msx1
d/d
Msx2
d/d 
mice. The uterine epithelium lacking Msx1 and Msx2 exhibited persistent 
proliferative activity. The undifferentiated glandular epithelial cells fail to express critical 
glandular factors such as Lif and undifferentiated luminal epithelium fail to acquire the receptive 
state. These results indicate that uterine specific deletion of Msx homeobox genes renders mouse 
infertile due to a lack of uterine receptivity.  
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Gene expression profiling of uterine stromal and epithelial cells showed elevated expression of 
several members of the Wnt gene family. The enhanced Wnts activated β-catenin in uterine 
stromal cells and stimulated the production of a subset of fibroblast growth factors (FGFs). The 
FGFs secreted from the stromal cells acted through the FGF receptors present in the epithelium 
to promote epithelial proliferation. This persistent proliferation prevented the uterus to achieve 
the receptive phase during embryo implantation. Collectively, these results uncovered a unique 
signaling network, involving Msx, Wnts, and FGFs, which regulate stromal-epithelial 
communication critical for acquisition of uterine receptivity.  
 
Finally, we investigated the role of Msx homeobox genes during stromal decidualization. Mice 
lacking Msx1 and Msx2 in their uteri failed to exhibit decidual response during experimentally 
induced decidualization. Further experiments revealed that these genes regulate stromal cell 
differentiation but not proliferation during decidualization. Our studies also revealed that MSX1 
and MSX2 critically regulate human endometrial stromal cell differentiation. In both mice and 
humans, the Msx genes act downstream of BMP2 in mediating stromal cell decidualization. 
 
Collectively, this study provides an insight into the molecular mechanisms underlying 
endometrial receptivity and stromal decidualization for embryo implantation. It may help to 
design the treatment protocol for reproductive disorders and to improve the success rate of 
assisted reproductive technologies in treating infertility in women. 
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